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ABSTRACT 
Biomaterials are composed of a wide array of macromolecules and have impacted multiple 
biomedical technologies. Structurally, each of these materials typically only include a small 
set of monomers that limits their structural complexity, tunability, and functionality. There 
is a critical need to develop novel biomaterials with greater complexity and tailored 
functionalities to meet the demands of emerging new technologies in drug delivery, tissue 
engineering, and regenerative medicine. Inspired by proteins, where complexity and 
functionality are driven by the organization of thousands of functional domains, we 
hypothesized that tethering different biomaterial backbones into a domain-structured 
single-chain polymer (a polymer mosaic) will impart structural complexity with emergent 
physicochemical properties, novel functionalities, and defined secondary structures.  
 
In this thesis, we designed and characterized a series of polymer mosaics designed to test 
this hypothesis. We first designed and synthesized an alginate-b-polyethylene glycol 
(PEG)-b-polylactide (PLA) triblock copolymers utilizing a modular click-chemistry 
strategy. This triblock copolymer was investigated as an amphiphilic material for 
  
 vii 
controlled drug release. The incorporation of a hydrophobic PLA domain and a hydrophilic 
alginate domain in a single polymer made it an attractive platform for both the 
encapsulation and release of both hydrophilic and hydrophobic small molecules. 
Nanoparticles (NPs) formulated from this triblock displayed morphologically discrete 
compartmentalization of the alginate domains, superior loading efficiencies of both 
hydrophilic and hydrophobic small molecules, and potential as a drug-combination 
delivery platform. Next, we evaluated the potential of alginate-b-PLA diblock copolymers 
to function as degradable hydrogels by combining the hydrogel-forming feature of alginate 
with the degradation properties of a PLA domain. The fabricated hydrogels had tunable 
degradation properties from days to weeks by modulating their formulation, and are being 
evaluated as potential sacrificial scaffolds for tissue engineering. Finally, poly (L-lactide)- 
poly (amido saccharide) (PLLA-PAS) were synthesized as polymer mosaics amphiphiles 
with defined secondary structures that formulate into chiral nanoparticles. These chiral 
particles assembled a unique protein corona of 22 proteins when incubated with mouse 
serum and analyzed by SDS-PAGE and LC/MS-based proteomics. This result will build a 
foundation to further our understanding of surface chirality on the protein corona and its 
potential delivery applications. 
 
In summary, we successfully synthesized and developed polymer mosaics with 
complementary properties, tailored functionalities, and defined secondary structures.  
These new materials can pave the way for advances in new technologies for drug delivery 
and tissue engineering.  
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Chapter 1 Introduction 
1.1 Abstract   
 
This chapter provides a general overview of the area of block copolymers (BCPs) focusing 
on the major types of BCPs, synthetic strategies, and self-assembly. The general concept 
of click chemistry is introduced, followed by a discussion of the inverse-electron demand 
Diels-Alder (IEDDA) reaction and its applications in biomaterial synthesis and 
modification. The objective of this chapter is to provide background information to better 
understand “polymer mosaic”, a series of domain-structured single-chain polymers 
achieved by tetrazine and trans-cyclooctene mediated inverse electron demand Diels-Alder 















1.2 Block Copolymer-based Delivery Systems  
1.2.1 Overview of Block Copolymers (BCPs)  
 
 
Figure 1. 1. Representative structures of block copolymers: (A) Linear block copolymer (B) 
“Comb” grafted copolymers (C) “Miktoarm” star copolymers (D) Cyclic block copolymers 
 
Copolymers are typically categorized into four major categories: random, alternating, 
block and graft copolymers. Block copolymers are a chemically linked pair of 
homopolymers, classified by the sequential arrangement of the component segment. The 
simplest linear block copolymer is the AB diblock copolymer where two different 
homopolymers from A and B monomer units are linked in an end-to-end fashion. In the 
case of ABC triblock copolymers or multi-block copolymers, homopolymers from 
different monomers are connected in a sequential and defined order (Figure 1A). Instead 
of linear block copolymers, nonlinear block copolymers include star, graft, “miktoarm” 
star, cyclic block copolymers (Figure 1B-D)and among others1.  
 
Compared to homopolymers, block copolymers permit the combination of distinct 
chemical properties within a single macromolecule and offer tailored functionalities such 
as degradability2 and stimuli responses including pH3, light4, temperature5, enzyme6, 
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glucose7,8, and reduction/oxidation9,10. Due to their excellent biocompatibility, structural 
and morphological versatility, and flexible synthetic implementation, BCPs have been 
widely used in drug delivery11, nanoreactors12, and tissue engineering13.  
 
1.2.2 Synthesis of Block Copolymers 
In the past decades, a wide range of block copolymer structures have been synthesized 
including linear14, graft,15 dendritic16, star-like17, hyperbranched18, and so on. This section 
will briefly discuss the general synthesis strategies of block copolymers to produce 
macromolecules with tailored properties. The synthetic strategies can be broadly divided 
into three categories: sequential polymerization, macroinitiation, and post-polymerization 
coupling.   
 
For sequential polymerization, two or more monomer sets are used to grow a single 
polymer chain. This strategy is applicable to methods such as living ionic, reversible-
deactivation radical polymerization, and ring-opening polymerization. For example, living 
anionic polymerization achieves quantitative conversion without chain transfer and/or 
chain termination. It has been widely exploited in industry to create BCPs on a massive 
scale due to its superior control over molecular weight and excellent end-group fidelity. 
Although a broad range of block copolymers can be synthesized from sequential 
polymerization strategy, this method is limited by the number of available monomers and 
their variability in their reactivity19.  
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To overcome the limitation of sequential polymerization, macroinitiation can be used to 
create BCPs with desired multiple block functionalities. In general, this strategy usually 
involves a two-step polymerization process where the macroinitiator with excellent end 
group fidelity is first produced for effective and efficient chain extension of the next 
building block. Therefore, similar or orthogonal reactions can be used between 
macroinitiator synthesis and chain extension. Meanwhile, macroinitiation is also very 
effective in preparing nature-derived BCPs that feature polysaccharides and proteins. For 
example, Sumerlin et al. firstly synthesized bovine serum albumin (BSA) based chain 
transfer agent (BSA-macro-CTA) and subsequently used to synthesize BSA-poly (N-
isopropylacrylamide) (BSA-PNIPAM). This polymer-protein conjugation was synthesized 
via a reversible addition-fragmentation chain transfer (RAFT) polymerization, and the 
resulting hybrid biopolymer exhibited temperature-responsive protein activity where the 
protein-polymer conjugate purified at 25 °C retain 92% activity but its activity reduced to 
75% when the precipitation temperature was above the LCST of PNIPAM to 40 °C20.  
 
For post-polymerization coupling strategy, it enables the synthesis of block copolymers 
with distinctive chemistries and properties. This approach is involved with polymerization 
of monomers with functional groups that are inert towards the polymerization condition 
but can be quantitatively converted in a subsequent reaction. This coupling strategy allows 
access to functionality that cannot be prepared by direct polymerization as well as 
combinatorial materials discovery21. Different classes of reactive polymer precursors 
bearing chemoselective handles such as active esters22, thiol23,24, and azide25 have been 
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used for block copolymer synthesis.  
 
One effective method to link different building blocks is facilitated by click chemistry. 
Different highly efficient reaction types including copper (I)-catalyzed azide-alkyne 
cycloaddition26, thiol-X conjugation27, inverse electron demand Diels-Alder (IEDDA)28 
were widely used in block copolymer synthesis and modification. The overview of click 
chemistry and the application of IEDDA reaction, which is the major conjugation strategy 
for the dissertation, will be discussed in Section 1.3. However, few challenges must also 
take into consideration when applying click chemistry in the synthesis and purification of 
BCPs. For example, the coupled BCPs mixture might contain un-coupled building blocks 
if the end-fidelity is not maintained. In this case, it can be difficult and time-consuming to 
remove the un-coupled building blocks29.  
 
Meanwhile, it is worth noting that not all small molecule click chemistry is effective in 
polymer synthesis. For example, the radical mediated thiol-ene is an effective method in 
small molecule and polymer modifications30, but it has not been as efficient in polymer-
polymer conjugation31. Another challenge to overcome is to identify compatible solvents 
for each building block, which, if not properly addressed, can lead to low yields, 
incomplete reaction mixture, and high dispersity.  
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1.2.3 Self-Assembly of Block Copolymers in Solution 
Compared to self-assembly process in bulk, assembly process of amphiphilic block 
copolymers is more complicated in solution where the prediction of particle morphology 
is difficult. Different techniques have been used to characterize and understand self-
assembly process of BCPs. For example, dynamic and static light scattering (DLS and 
SLS)32, calorimetry33, spectroscopy such as nuclear magnetic resonance (NMR) and 
Raman34, and rheology35 are used to follow gross aggregation evolution. On the other hand, 
techniques such as negative staining TEM and cryo-TEM36 are capable of probing the 
morphological details of self-assembly structures.  
 
 
Figure 1. 2. Morphology of self-assembled BCPs can be estimated by “packing parameter”. 
Reprinted from ref. 11. Copyright 2009 Wiley-VCH.  
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In theory, the morphology of amphiphilic BCPs can be estimated by the dimensionless 
packing parameter (P=n/a0lc) where n is the volume of hydrophobic chain, a0 is the area of 
hydrophilic head group, and lc is the length of hydrophobic tail normal to interface. As a 
general rule, when P£ 1/3, spherical micelles are generally formed, rod-like micelles are 
favored when 1/3£P£1/2, and vesicles for 1/2£P£111. However, it should be noted that the 
exact p-value is difficult to precisely calculate and such as concept is merely served as a 
qualitative measure to explain morphological transition during BCPs self-assembly 
process37.  
 
Among different self-assembly strategies, polymerization-induced self-assembly (PISA) 
has been established as an efficient and robust approach to induce intermolecular nano-
aggregates with controlled morphologies, tunable dimensions, and diverse functions. 
Reversible addition-fragmentation chain transfer (RAFT) polymerization has been the 
most widely used technique. Typically, a soluble homo-polymer is chain-extended using a 
second monomer in a suitable solvent in which the growing of the second block gradually 
becomes insoluble to drive the self-assembly of block copolymers38 Parameters such as 
monomer solubility, radical initiator concentrations, macro-CTA designs have been 
explored to facilitate the formation of different morphologies 37. Well-defined nano-objects 
with a wide variety of morphologies have been achieved including spheres, 
worms/fibers/cylinders, lamellae, vesicles, hexagonally packed hollow hoops 39, silks/films, 
ribbons 40, and framboidal vesicles 41–44. However, stringent requirement for 
monomer/polymer solubility limits chemical versatility of PISA.  
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Intramolecular folding of well-defined linear block copolymers into single chain 
nanoparticles (SCNPs) is an alternative approach in which one polymer chain folds into a 
particle of nano-sized dimensions. Three major intramolecular folding motifs including 
covalent crosslinking, non-covalent interactions, and dynamic covalent chemistry have 
been utilized to synthesize SCNPS inspired by nature 45. However, development of 
synthetic polymers with precise and guided folding exhibited by natural materials is still 
challenging. The effects of chain length, placement of crosslinking within a polymer chain, 
and rigidity of polymer backbone have not been fully explored 46. 
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1.3 Inverse Electron Demand Diels-Alder (IEDDA) Reaction in Modifications of 
Biomaterials  
 
1.3.1 Overview of Click Chemistry  
 
As introduced by Sharpless and co-workers in 2001, “click” chemistry has rapidly 
influenced many research fields. As defined by Sharpless et al., reactions that: “must be 
modular, wide in scope, high very high yields, generate only inoffensive by-products (that 
can be removed without chromatography), are stereospecific, The required process 
characteristics include simple reactions (ideally, the process should be insensitive to 
oxygen and water), readily available starting materials and reagents, the use of no solvent 
or a solvent is benign (such as water) or easily removed, and simple product isolation.” 47 
 
In the past decades, click chemistry has garnered a significant attention in chemical 
biology48, drug development49 as well as biomaterial synthesis and modification50. A wide 
array of reaction types such as azide-based copper-catalyzed and strain-promoted 
cycloaddition, thiol-X conjugation reactions, and the inverse electron demand Diels-Alder 
reaction were introduced. Compared to conventional conjugation chemistry, many click 
reactions are orthogonal to common functional groups found in polymers, proteins, and 
cells including amines, carboxylic acid, alcohols, and so on. Meanwhile, they have 
favorable reaction rates under benign condition with a minimum number of byproducts. 
Due to these advantages, click chemistry offers an opportunity to readily modify the 
polymer chain ends or pedant groups to achieve novel properties and structures.  
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Due to the enormous range of click chemistry reactions and number of publications in the 
past decades, it is beyond the scope of this thesis to thoroughly review this topic and 
excellent reviews have been published in the applications of click chemistry in chemical 
biology48, polymer modifications51, and drug delivery52. However, the application of the 
inverse electron demand Diels-Alder (IEDDA) reaction in biomaterials will be briefly 
discussed  
 
1.3.2 Inverse Electron Demand Diels-Alder (IEDDA) Reaction  
The inverse-electron demand Diels-Alder (IEDDA) reaction between tetrazine and a 
strained double bond is rapid bio-orthogonal reaction, which has been widely used in 
labeling cells and biomacromolecules53.   
 
Among IEDDA reactions, tetrazine-norbornene is a fast and high-yielding reaction at room 
temperature without addition of catalyst or stimulus. For example, O’Reilly and co-works 
reported a series of diblock copolymers through end modification of polymers using 
tetrazine-norbornene ligation chemistry. Amphiphilic block copolymer of polystyrene -b- 
polyethylene glycol (PS-b-PEG) were synthesized in CH2Cl2/DMSO mixture (1:1) and 
hydrophilic polymer-polymer conjugation attempt between poly (N-isopropylacrylamide) 
(PNIPAM) and PEG was also successful in water. However, the conjugation between poly 
(d-valerolactone) (PVL) and PEG in CH2Cl2 was not complete29. Similarly, tetrazine-
norbornene reaction was also used to synthesize single chain polymer nanoparticles 
(SCNPs) where pedant norbornenes modified polystyrene was reacted with a bifunctional 
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tetrazine crosslinker54. Dove and co-workers also developed norbornene-functionalized 
poly (carbonate)s by ring opening polymerization. The pedant norbornene groups provide 
reactive sites for various post-polymerization modifications ranging from 1,2-dipolar 
cycloaddition, IEDDA, to radical thiol-ene coupling55. Tetrazine-norbornene reaction also 
provides a facile way to fabricate biocompatible hydrogels. For example, clickable alginate 
hydrogels were also developed where alginate was functionalized with tetrazine and 
norbornene. Moreover, the mouse pre-osteoblast cell line was viable and proliferated in the 
resulting hydrogels over 7 days56. 
 
Figure 1. 3. Reaction scheme of tetrazine-trans-cyclooctene-mediated inverse electron demand 
Diels-Alder reaction.   
 
More recently, the tetrazine-trans-cyclooctene (TCO) reaction is found to be one of the 
fastest click reactions with a k2 up to 106 M-1 s-1 without a catalyst and at almost 100% 
conversion at micromolar concentrations at room temperature. For example, tetrazine-TCO 
chemistry has been used to synthesize homodimeric PNIPAM-T4 lysozyme conjugate 
where T4 lysozyme was modified with TCO followed by ligation with bis-tetrazine 
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PNIPAM. The yield of tetrazine-TCO ligated PNIPAM-T4 lysozyme (38%) is also higher 
than conventional thiol-maleimide conjugation (<1%)57. Tetrazine-TCO ligation was also 
used to create meter-long multiblock copolymer microfibers. The resulting microfibers 
containing fibronectin-derived integrin-binding peptide side provided appropriate 
biochemical signals to promote both fibroblasts and myoepithelial-like cells58. Core-shell 
patented synthetic hydrogels were fabricated using tetrazine modified hyaluronic acid, bis-
TCO crosslinkers and monofunctional TCO conjugates to provide enzymatic degradability 
and cell adhesivity. Spatial control of stem cell behavior without specialized equipment 






Chapter 2 Development and Characterization of Alginate/PEG/PLA Amphiphilic 
Block Copolymer as a Small Molecule Codelivery Platform  
 
2.1 Abstract 
This chapter focuses on the synthesis and characterization of an ABC-type alginate-based 
triblock copolymer that features the backbones of three distinct biomaterials. The chapter 
starts with the detailed synthesis of triblock copolymer by the end-group covalent 
attachment of alginate with a PLA/PEG diblock copolymer using an electron inverse 
demand Diels Alder reaction. Next, the combination of a hydrophilic alginate and PEG 
domains with hydrophobic PLA domains result in an amphiphilic triblock copolymer that 
self-assembles under aqueous conditions into nanoparticles by nanoprecipitation. The 
resulting nanoparticles have a spherical structure 30-50 nm in diameter and 
morphologically display discrete compartmentalization of the alginate domains. Lastly, 
theses triblock nanoparticles are a versatile platform that can encapsulate both hydrophilic 
and hydrophobic small molecules and show great potential as drug delivery systems for 




2.2 Background  
 
The self-assembly of macromolecular structures into highly-ordered, functional 
nanomaterials is a prominent feature of biological systems. Proteins are quintessential 
examples of these nanomaterials with their diverse structures enabling many of the 
functions necessary for life. The shuffling and combination of hundreds of conserved 
regions, or domains, of these large molecules is one hypothesis for how proteins evolved 
their complexity60. Recently, different synthetic strategies have been developed to mimic 
the assembly behaviors of proteins including polymerization-induced self-assembly61, 
crystallization-driven self-assembly62, and bottlebrush polymer synthesis63. Amphiphilic 
block copolymers are a set of materials that have demonstrated an ability to self-assemble 
into well-organized structures at the nanoscale (e.g., nanoparticles, micelles, vesicles, and 
thin films) that have facilitated applications in drug delivery, catalysis, and sensing64–66. 
Generally, amphiphilic block copolymers consist of hydrophobic core-forming blocks and 
hydrophilic shell-forming blocks upon dispersing in aqueous media, and have featured 
crystallizable segments67, peptide amphiphiles68, macrocycles69, and dendrons70. While a 
myriad of synthetic hydrophobic or hydrophilic polymers have been developed, 
polysaccharide containing amphiphilic block copolymers have also gained a significant 
attention in recent years. For example, acetylated maltoheptose and poly (amino acid) 
block copolymer was developed as a reactive oxygen species-responsive drug delivery 
system for nitrogen mustard prodrug to tumor cells71. An amphiphilic polysaccharide 
derived from dextran was also developed with pH-responsive drug release72. Huang. et al. 
also developed docetaxel-loaded nanoparticles using hyaluronic acid/ poly (D,L- lactide-co-
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glycolide) block copolymers that targeted CD44 receptors in breast cancer32. Synthetic 
glucose-based amphiphilic block copolymers developed by Wooley and coworkers have 
shown self-assembly into spherical, cylindrical, or thin, ribbon-like nanostructures 
depending on the compositions and domain sizes73–75.  
 
Currently there have been few studies into alginate-containing amphiphilic block 
copolymer materials. Among different polysaccharides, alginates are naturally anionic 
polymers consisting of b-D- mannuronic acid (M) and a-L-guluronic acid (G) isomeric 
monomers. Alginate has been widely investigated and used for many biomedical 
applications such as would dressing 76, cell encapsulation 77, and drug delivery systems78 
due to its biocompatibility, low toxicity, and facile gelation in the presence of divalent 
cations such as Ca2+ and Ba2+. Different approaches have focused on modulating alginate 
properties by grafting copolymers via chemically modification of the polymer’s hydroxyl 
or carboxyl groups. Alginate-based comb copolymers were synthesized by reversible 
addition-fragmentation chain transfer (RAFT) with poly (oligo ethylene glycol 
methacrylate). The resulting comb copolymers self-assembled into nanoparticles ranging 
between 100-500 nm when introducing calcium chloride79. Kapishon et al. developed poly 
(methyl methacrylate) grafted alginate by single electron-transfer living radical 
polymerization that also self-assembled into nanoparticles80. While end modification of 
polysachharides like alginate can be chemically challenging, recent reports have 
successfully developed methods that enable the covalent modification of the reducing end 
of alginate81.  
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To develop an amphiphilic block copolymer (BCPs), we chose to combine alginate 
domains with both polylactic acid (PLA) and polyethylene glycol (PEG) as the other two 
building blocks.  PLA is one of the most widely used polymers in biomedical fields due to 
its biocompatibility, biodegradability, tailored properties, and well-established 
formulations82. PLA is also used as a core-forming domain in block copolymers to aid self-
assembly in aqueous systems due to its hydrophobicity83. PEG, a hydrophilic polymer, has 
been shown to improve the stability and pharmacokinetic profiles of BCP-based 
nanoparticles84.  
 
Here, we present the first synthesis, characterization, and evaluation of an alginate-based 
ABC-type triblock copolymer. Alginate, PEG, and PLA polymers were tethered end-to-
end into a single macromolecule utilizing an inverse electron-demand Diels-Alder reaction 
to achieve robust reactivity and selectivity (Scheme 2.1). The resulting triblock polymer, 
which we call a “polymer mosaic,” features the three polymer backbones as domains in a 
single polymer chain with an alternating backbone architecture. These amphiphilic block 
copolymers can self-assemble into nanoparticles that display compartmentalized 
morphologies in aqueous solutions. These mosaic nanoparticles can encapsulate both 
hydrophobic and hydrophilic small molecule payloads with minimal changes made to 
particle formulation. To the best of our knowledge, this is the first report of an alginate-
based amphiphilic triblock copolymer that self-assembled into nanoparticles, showing 











2.3 Results  
2.3.1 Triblock Copolymer Synthesis 
Previous reports have used “click” reactions such as the copper-catalyzed azide-alkyne 
cycloaddition (CuAAAC) coupled with reductive amination to modularly synthesize 
polysaccharide based amphiphilic di-block copolymers85,86. However, such strategies 
usually require harsh conditions (i.e., high temperature), prolonged reaction times, and 
removal of the metal catalyst. The inverse electron-demand Diels-Alder reaction between 
tetrazine and strained alkenes is a rapid orthogonal reaction that is tolerant to a wide array 
of latent chemical functionalities87. Trans-cyclooctene is one of the most reactive partners, 
and reacts with tetrazine rapidly under atmospheric conditions at room temperature and 
does not require a catalyst.53. Tetrazine-trans-cyclooctene ligation has been used to develop 
homodimeric T4 lysozyme-poly (N-isopropylacrylamide) conjugates57, PEG based 
multiblock copolymer microfibers through interfacial polymerization58, and polypeptide-
b-polypeptoids88. However, such a “click” chemistry strategy has not been used to 
synthesize a polysaccharide-based block copolymer. Therefore, to synthesize the triblock 
copolymer, we decided to use the inverse electron-demand Diels-Alder mediated click 
reaction due to its rapidity and orthogonality with other functional groups such as the 





Figure 2. 1. Characterizations of alginate hydrolysis. (A) Mn change of alginate hydrolysis from 
3,6, to 15 hours. (B) PDI change of alginate hydrolysis from 3,6, to 15 hours. (C) Poly-G percentage 
change from 3,6, to 15 hours. 
We installed the tetrazine moiety through the chemo-selective end modification of alginate 
via oxime formation with the reducing end of hydrolyzed alginate89 (Figure 2.1). We 
hydrolyzed our alginate biopolymer to a molecular weight of 4000 g/mol to make the 
polymer easier to handle synthetically, while enriching for a high guluronic acid content 
(~ 80%) to maintain the polymers ability to form strong ionic crosslinks90.  Oxime 
formation was an attractive transformation for end modification since aminooxy reagents 
react selectively with the reducing terminal of a polysaccharide in aqueous medium under 
mildly acidic conditions (Figure 2.3)81. To incorporate tetrazine to the reducing end of 
alginate, we synthesized a dual-linker containing both aminooxy and tetrazine moieties 











Figure 2. 3. The chemical structure of alginate-oxime-tetrazine 3 was characterized by 1H-NMR 
(D2O, 500 MHz) with peak assignments.   
 
The trans-cyclooctene-bearing macromolecule, the PLA-b-PEG-TCO diblock, was 
prepared through the ring opening copolymerization of lactide monomer using TCO-

















(5a) D, L-Lactide TCO-PEG112-OH 50 8981.2 8572.3 1.06 
(5b) D, L-Lactide TCO-PEG112-OH 75 11957 11585 1.03 
(5c) D, L-Lactide TCO-PEG112-OH 150 18993 16214 1.17 
 
Table 2. 1. GPC summaries of (5a) PLA50-b-PEG112-TCO. (5b) PLA75-b-PEG112-TCO. (5c) 
PLA150-b-PEG112-TCO using THF gel permeation chromatography (1 ml/min) and polystyrene 
standards. 
When ligating the sodium alginate-tetrazine with the PLA-b-PEG-TCO diblock, one major 
challenge is the solubility difference of these two macromolecules in organic solvents: 
sodium alginate is only water soluble while the PLA-b-PEG-TCO can be dissolved in polar 
organic solvents. To improve the organic solubility, sodium alginate-tetrazine was 
converted into its tetrabutylammonium (TBA) salt through ion exchange. The resulting 
TBA-alginate-tetrazine salt was readily solubilized in aprotic solvent such as DMF or 
DMSO and readily ligated for the “polymer mosaic” synthesis. The reaction typically 
changed in color from pink to colorless within 30 minutes and the final triblock copolymer 
was characterized by1H-NMR, UV-Vis spectrometer and FT-IR.  When dissolving in D2O, 
the characteristic peaks of PLA were not observed, only peaks consistent with the alginate 
and polyethylene glycol backbone. The loss of proton signals from the polylactide in D2O 
indicated that the triblock copolymer exhibited potential hydrophobic aggregation in 
solution (Figure 2.5 A). The 1H-NMR of the triblock in DMSO-d6 revealed specific peaks 
corresponding to the methyl (-CH3) and -CH- groups of the polylactide backbone at 5.10 
ppm and 1.40 ppm. Moreover, the -CH2- group from polyethylene glycol backbone was 
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also observed in 3.50 ppm. In DMSO-d6, the characteristic peaks of alginate were not 
observed, consistent with aggregation of these hydrophilic domains of the polymer (Figure 
2.5 B). Diagnostic peaks for tetrazine (7.42 and 8.23 ppm) from the alginate-tetrazine and 
TCO functionalities from the diblock (5.40 and 5.54 ppm) disappeared after conjugation 




Figure 2. 5. Characterizations of alginate-b-PEG112-b-PLA: (A) 1H-NMR characterization of 
alginate-b-PEG112-b-PLA and full consumption of tetrazine and TCO was observed (D2O, 500 
MHz). The alginate and PEG backbones are marked in red and purple boxes. (B) 1H-NMR 
characterization of alginate-b-PEG112-b-PLA and full consumption of tetrazine and TCO was 
observed (DMSO-d6, 500 MHz) Peaks marked with * are tetrabutylammonium peaks. The 
designated peaks for PEG and PLA domains were marked. 
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FTIR analysis showed the anticipated stretching vibrations of OH groups from alginate at 
3412 cm-1, as well as the asymmetric and symmetric stretches of the C=O from the 
carboxylate appeared in 1608 and 1467 cm-1 (Figure 2.6). The stretching of C=O from the 
polylactide was identified at 1752 cm-1 along with -CH stretching at 2961 cm-1. For the 
PEG domain, -CH stretching was identified at 2876.  
 
 
Figure 2. 6. FTIR characterizations of individual block copolymer and alginate-b-PEG112-b-PLA: 
(A) FTIR of alginate-oxime-tetrazine and signature peaks were marked on the spectrum. (B) FTIR 
of PLA-b-PEG112-TCO block copolymer 5 and the signature peaks were marked on the spectrum. 
(C) FTIR of alginate-b-PEG112-b-PLA triblock copolymer 6 and the signature peaks were marked 
on the spectrum. 
 
For UV-Vis spectrum, the signature of alginate-oxime-tetrazine at 525 nm disappeared 
after conjugated with PLA-PEG112-TCO indicating the fully consumption of tetrazine 
functionality (Figure 2.7). Taken together, these characterizations confirmed the synthesis 




Figure 2. 7. UV-Vis spectra of alginate-oxime-tetrazine and alginate-b-PEG112-b-PLA 
 
2.3.2 Self-Assembly of Triblock Copolymer Nanoparticles  
Nanoparticles were formulated from the triblock mosaic by nanoprecipitation32, where the 
alginate domain was crosslinked in the presence of barium chloride after particle formation. 
The impact of different concentrations of barium chloride (0.5-5 mM) was determined by 
both hydrodynamic diameter and zeta potential. The average hydrodynamic meters of 
nanoparticles were 30-50 nm in the presence of 0.5 and 1mM barium chloride. When 
barium chloride concentration was increased to 1 mM or 5 mM, the particles formed larger 
aggregates indicated by the larger hydrodynamic diameters from nano to micro meters 
(data not shown), as well as a sharp shift from -37.09 to -8.38 mV for zeta potential (Figure 





Figure 2. 8. Zeta potential measurement of alginate/PEG/PLA triblock copolymer NPs with barium 







Figure 2. 9. Size and morphology characterizations of mosaic triblock nanoparticles. (A) The size 
distribution of Alginate-b-PEG112-b-PLA50 aggregates measured by DLS (Ba2+: 1 mM). (B) The 
size distribution of Alginate-b-PEG112-b-PLA75 NPs measured by DLS (Ba2+: 1 mM). (C) The size 
distribution of Alginate-b-PEG112-b-PLA150 NPs measured by DLS (Ba2+: 1 mM). (D) The 
morphology of Alginate-b-PEG112-b-PLA50 aggregates observed by Cryo-TEM (Ba2+: 1 mM) and 
no discernible nanoparticles were observed.  (E) The morphology of Alginate-b-PEG112-b-PLA75 
NPs observed by Cryo-TEM (Ba2+: 1 mM, scale bar: 200 nm) and discrete alginate domains were 
identified on the surface of nanoparticles. (F) The morphology of Alginate-b-PEG112-b-PLA150 NPs 
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observed by Cryo-TEM (Ba2+: 1 mM, scale bar: 40 nm) and discrete alginate domains were 
identified on the surface of nanoparticles. 
The morphologies of these triblock nanoparticles were characterized by both cryo-TEM 
and negative staining TEM. (Figures 2.9 and 2.10). PLA domains under MW 4000 g/ml 
did not form stable nanoparticles and aggregates were observed, likely due to insufficient 
hydrophobicity to drive the self-assembly of triblock copolymer in aqueous solution 
(Figure 2.9 A). With PLA domains greater than 7000 g/mol, stable spherical nanoparticles 
were observed (Figure 2.9 B and C). The PLA domain formed the core of nanoparticles 
due to its hydrophobic nature, which was also supported by the loss of proton signals from 
PLA in 1H-NMR when dissolving in D2O. Notably, these nanoparticles morphologically 
display discrete compartmentalization of their alginate domains, which were visualized in 
both cases where more electron dense (darker) regions of the cryo-TEM images indicated 
the barium-crosslinked alginate domain (Figure 2.9 D-F). These observations were also 
consistent with zeta potential studies where the negative value of zeta potential indicated 
the formation of alginate compartments closer to the particle surface due to the presence of 





Figure 2. 10. Negative staining TEM characterizations of Alginate/PEG/PLA triblock copolymer 
NPs. (A) Alginate-b-PEG112-b-PLA50 aggregates (scale bar: 60 nm). (B) Alginate-b-PEG112-b-
PLA75 NPs (scale bar: 200 nm). (C) Alginate-b-PEG112-b-PLA150 NPs (scale bar: 60 nm).   
Furthermore, the presence of PEG on the surface of the nanoparticles was verified by a 
PEG ELISA test (Figure 2.11). The assay indicated binding of an anti-PEG antibody to 
free PEG112 (MW: 5000 g/mol), alginate-b-PEG112-b-PLA75 NPs, and alginate-b-PEG112-b-
PLA150 NPs. This result is consistent with the presence of PEG on the surface of the 
nanoparticles. Notably, alginate alone did not show binding to the anti-PEG antibody. 






Figure 2. 11. Competitive anti-PEG ELISA of triblock copolymer NPs, alginate, and free PEG 
controls. Data are presented mean ±SD (n=2). 
 
2.3.3 Payload Encapsulation, Release and Cellular Uptake of Mosaic Nanoparticles  
The amphiphilic nature of the triblock mosaic nanoparticles together with the observation 
of spatial compartmentalization of the different polymer domains lead us to hypothesize 
that these particles could be a versatile nanocarrier for diverse payloads. To investigate 
their capability to encapsulate and release diverse molecules, nanoparticles were loaded 
with both fluorescence dyes and therapeutic drugs with different hydrophobicities (Figure 
2.12). Among the fluorescent payloads we tested, the dye rhodamine B is the most 
hydrophilic with a log P of 1.95, while coumarin 6 was more hydrophobic with a log P of 
4.79. To cover a wide range of drug structures and a range of 
hydrophobicities/hydrophilicities, we also evaluated: (a) azathioprine, an 
immunosuppressive agent with a log P of 0.1, (b) doxorubicin (free base), a 
chemotherapeutic drug with a log P of 1.27, (c) erlotinib, an EGFR inhibitor has a log P of 
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2.7, and (d) irinotecan, a chemotherapeutic drug with a log P of 3.2. In general, for each 
individual payload, the encapsulation is higher for alginate-b-PEG112-PLA150 nanoparticles 
compared to PLA75 triblock nanoparticles (Figure 2.12). Particularly, loading efficiency 
of different payloads varies from 17-80% for PLA75-domain nanoparticles and 26-90% for 
PLA150-domain nanoparticles. Furthermore, to validate the additional benefit of 
incorporation of alginate domain, we compared the encapsulation efficiency of different 
payloads between polymer mosaic and PLA-b-PEG nanoparticles. Particularly, loading 
efficiency of various payloads for PLA75 based mosaic nanoparticles is 2.0–6.5 fold 
increase compared to PLA75-b-PEG112 diblock copolymer nanoparticles (Figure 2.12). 
Similarly, there is 1.9–5.3 fold increase when comparing PLA150 mosaic nanoparticles to 





Figure 2. 12. Encapsulation efficiency of different payloads in (A) PLA75-domain mosaic NPs and 
(B) PLA150-domain mosaic NPs.  A 2.0–6.5 fold increase in encapsulation was observed for PLA75-
domain mosaic NPs and a 1.9-5.3 fold increase was observed for PLA150-domain NPs compared to 
corresponding PLA-b-PEG NPs among payloads. In all cases, data are represented as mean ± SD 
(n=3) and **: p<0.01. 
  
 35 
The payloads with smaller log P values (more hydrophilic) had faster release profiles 
within 48 hours (Figure 2.13). For example, for PLA75-domain triblock NPs, within the 
first 10 hours, about 60% of the rhodamine B was released. By comparison, for a more 
hydrophobic payload like coumarin 6 only 20% of the dye was released within the first 10 
hours. Both doxorubicin and erlotinib, which have more intermediate hydrophobicities, the 
NPs released about 40% of the drug within the first 10 hours.  
 
 
Figure 2. 13. Payload release from Alginate/PEG/PLA triblock copolymer NPs. (37 °C in 1´ PBS): 
(A) 48-hr release profile of rhodamine B and coumarin 6 from PLA75-domain mosaic NPs. 29.3% 
of coumarin 6 and 83.1% of rhodamine B were released at 48hrs. (B) 48-hr release profile 
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rhodamine B and coumarin 6 from PLA150-domain mosaic NPs. 24.5% of coumarin 6 and 64.5% 
of rhodamine B were released at 48hrs. (C) 48-hr release profile of therapeutic small molecules 
from PLA75-domain mosaic NPs. 40.6%-70.5% of release was observed among payloads at 48hrs. 
(D) 48-hr release profile of therapeutic small molecules from PLA150-domain mosaic NPs. 29.2%-
58.5% release was observed among payloads at 48hrs. 
 
The distinct release profiles between rhodamine B and coumarin 6 also make triblock 
copolymer nanoparticles a potential nanocarrier for the release of a combination of 
therapeutic payloads in a temporally- and spatially-controlled manner. To test this 
hypothesis and as a proof of concept, we developed a co-delivery formulation of the 
triblock copolymer nanoparticle loaded with rhodamine B and coumarin 6. The release 
profile of the co-delivery system was similar as each individual payload within the first 48 
hours showing that there was no interference during encapsulation and release process. 
Over 168 hours, 85% of the rhodamine B and 41% of the coumarin 6 was released for the 
alginate-b-PEG112-PLA75 NPs. For the alginate-b-PEG112-PLA150 NPs, there was 81% 





Figure 2. 14. Payload release from Alginate/PEG/PLA triblock copolymer NPs. (37 °C in 1´ PBS): 
(A) 168-hr co-release profile of rhodamine B and coumarin 6 from PLA75-domain mosaic NPs. 
29.3% of coumarin 6 and 83.1% of rhodamine B were released at 168 hrs. (B) 168-hr co-release 
profile of rhodamine B and coumarin 6 from PLA150-domain mosaic NPs. 33.1% of coumarin 6 
and 81.1% of rhodamine B were released at 168 hrs. 
For therapeutic payloads, we co-encapsulated azathioprine and irinotecan, which showed 
distinctive individual release profiles as a proof of concept. Within the first 48 hours, the 
co-release profiles were comparable to the single-payload formulations. Over 168 hours, 
77% of the azathioprine and 47% of the irinotecan was released for the alginate-b-PEG112-
PLA75 NPs. For the alginate-b-PEG112-PLA150 NPs, there was 67% azathioprine and 39% 
irinotecan released (Figure 2.15A and B). Doxorubicin and erlotinib are a promising 
combination therapy for cancer treatments, in which the inhibition of epidermal growth 
factor receptor (EGFR) could sensitize and synergize with doxorubicin92,93. Therefore, we 
also developed a co-delivery system of these compounds. Similarly, there was no observed 
interference between the payloads during the encapsulation and the drug release. Over 168 
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hours, 67% of the doxorubicin and 58% of the erlotinib was released for the alginate-b-
PEG112-PLA75 NPs. For the alginate-b-PEG112-PLA150 NPs, there was 58% doxorubicin 
and 45% erlotinib released (Figure 2.15C and D), both comparable release profiles 
compared to the single-payload formulations.  
 
 
Figure 2. 15. Payload release from Alginate/PEG/PLA triblock copolymer NPs. (37 °C in 1´ PBS): 
(A) 168-hr co-release profile of azathioprine and irinotecan from PLA75-domain mosaic NPs.     
47.1% of irinotecan and 76.8% of azathioprine were released at 168 hrs. (B) 168-hr co-release 
profile of azathioprine and irinotecan from PLA150-domain mosaic NPs. 39.0% of irinotecan and 
67.0% of azathioprine were released at 168 hrs. (C) 168-hr co-release profile of doxorubicin and 
erlotinib from PLA75-domain mosaic NPs. 57.9% of erlotinib and 67.3% of doxorubicin were 
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released at 168 hrs. (D) 168-hr co-release profile of doxorubicin and erlotinib from PLA150-domain 
mosaic NPs. 45.8% of erlotinib and 58.8% of doxorubicin were released at 168 hrs. In all cases, 
data are represented as mean ± SD (n=3). 
To evaluate cellular uptake of polymer mosaic nanoparticles, rhodamine B was loaded into 
nanoparticles and cell uptake was observed by confocal microscopy in HeLa cells. The 
mosaic nanoparticle-treated groups were internalized to a greater extent compared to pure 
rhodamine B treated cells (Figure 2.16A-D). This observation was confirmed and further 
quantified by flow cytometry. Both PLA75 and PLA150 mosaic nanoparticles treated groups 
resulted in ~100% cell labeling leading to ~40% increase when compared to pure 
rhodamine B (Figure 2.16E). The mosaic nanoparticles also exhibited a good cellular 
biocompatibility (87%–100% for 24-hour cell viability) within the 25–500 µg/ml (Figure 
2.17).  These findings support the mosaic nanoparticles as drug delivery systems for future 





Figure 2. 16. Cellular uptake of rhodamine and rhodamine encapsulated in mosaic triblock 
nanoparticles in HeLa cells. (A) Untreated cells. (B) Free rhodamine treated cells. (C) Alginate-b-
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PEG112-b-PLA75 NPs treated cells. (D)  Alginate-b-PEG112-b-PLA150 NPs treated cells. Dark blue 
is the cell membrane, cyan is the nucleus, and red is rhodamine. (E) Flow cytometry analysis of 
cells treated with free rhodamine or rhodamine encapsulated nanoparticles. Compared to free 
rhodamine B treated cells, almost 100% of cells were labeled for both PLA75 and PLA150-based 




Figure 2. 17. 24-hour cell viability study treated with both mosaic NPs and triblock copolymer and 
quantified by CellTiter Glo 2.0.  Mosaic NPs were biocompatible with 87%-100% cell viability 
from 25-500 µg/ml.  In all cases, data are represented as mean ± SD (n=3). 
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2.4 Discussion  
 
We have demonstrated the synthesis of a novel alginate-based ABC-type amphiphilic 
triblock copolymer with an inverse electron-demand Diels-Alder reaction. The resulting 
triblock copolymer can self-assemble into nanoparticles with diameters of 30-50 nm. The 
size of the hydrophobic PLA domain plays an important role in driving the self-assembly 
behaviors since only PLA75- and PLA150-domain triblock copolymers can form spherical 
nanoparticles where then the alginate domains are crosslinked by barium chloride to form 
discrete compartments on/near the particle surface. As a proof of their potential as 
nanocarriers, we showed that these mosaic triblock nanoparticles are a versatile delivery 
platform that can encapsulate diverse therapeutic payloads with minimal changes to 
particle formulation. A wide range of payloads with different hydrophobicities were 
efficiently encapsulated compared to PLA-b-PEG diblock copolymers. Furthermore, the 
release profiles showed distinctive temporal resolution that was consistent with the relative 
hydrophobicity (log P) of the encapsulated payloads. Molecules with smaller log P value 
exhibited higher release rate within selected candidates.  
 
Developing nanocarriers that can deliver a combination of drug payloads has received 
increased interest due to the potential for synergistic effects and the greater difficulty for 
diseases like cancer to develop drug resistance when compared to monotherapy94. The 
conventional administration of combination therapies often leads to insufficient therapeutic 
outcome due to their inconsistent pharmacokinetic profiles and biodistribution95. Therefore, 
a co-delivery system that is not only capable of encapsulating various payloads but also 
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differentiating the release profiles and even therapeutic targets will exhibit stronger 
combination effects. Recently, different block copolymer-based systems have been 
developed for combination therapy. For example, methoxy PEG-PLGA copolymer 
nanoparticles have been developed for co-delivery doxorubicin and paclitaxel where the 
release profile of both drugs was simultaneous96. On the other hand, a co-delivery of 
doxorubicin and gefitinib with a sequential release profile was developed through both 
ionic paring and drug conjugation strategies97. Compared to those studies, the 
alginate/PEG/PLA triblock copolymer system reported here encapsulated various 
therapeutic payloads through a readily implemented nanoprecipitation method and 
achieved sequential release profiles without further modification of the polymers. In 
addition, the mosaic nanoparticles also showed significant levels of cellular uptake and 
good cytocompatibility, further underscoring the potential of this triblock-based 
nanoparticles for use as a co-delivery system. The diverse payloads we tested show promise 
for the application of these mosaic nanoparticles in models for diseases like cancer and 
autoimmune diseases like type 1 diabetes. Finally, these nanoparticles leave unmodified 
latent functionalities on the alginate domain (alcohol and carboxylic acid), which could be 
used as attachment points for targeting agents, producing targeted nanocarriers. Finally, 
the modular approach taken here to make these triblock polymer mosaics can be extended 
to include other biomaterial domains, further diversifying the properties of these polymer 




2.5 Material and Methods   
2.5.1 Chemicals  
Alginate (Pronova UPVLVG, Mn=31,000) was purchased from Novamatrix (Sandvika, 
Norway). a-amino-w-hydroxyl poly (ethylene glycol) hydrochloride (HO-PEG113-NH2× 
HCl, Mn=5,000 kg/mol, Jenkem Technology, Beijing, China). (4-(6-methyl-1,2,4,5-
tetrazin-3-yl) phenyl) methanamine was purchased from Click Chemistry Tools (AZ, 
USA). D,L-lactide, tBOC-aminooxy acetic acid, 1-[Bis(dimethylamino)methylene]-1H-
1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU), rhodamine B, 
coumarin 6, DMEM, Fetal Bovine Serum (FBS), CellMask Deep Red Plasma Membrane 
Stain, Hoechst 33342 Trihydrochloride were purchased from Thermo Fisher Scientific 
(MA, USA). Triethylamine, hydrogen chloride solution, 4M in dioxane, 1,8-Diazabicyclo 
[5.4.0] undec-7-ene (DBU) were purchase from Sigma-Aldrich (MO, USA). 
Tetrabutylammonium chloride (TBA chloride) was purchased from Chem-Impex (IL, 
USA). Doxorubicin was purchased from Cayman Chemical (MI, USA). Erlotinib was 
purchased from LC laboratories (MA, USA). Spectra/PorÒ 7 dialysis membrane (MWCO: 
2000/8000 Da), Spectra/PorÒ Float-A-Lyzer G2 (MWCO: 10,000 Da) were purchased 
from Repligen (MA, USA). PEGylated protein ELISA kit was purchased from Enzo Life 
Sciences (NY, USA). 35 mm poly-d-lysine coated dishes were purchased from Mattek 
(MA, USA). NIH-3T3 cells were a gift from Dr. Xin Brown at Boston University and 
maintained in high DMEM with 10% FBS.  
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2.5.2 Characterizations  
1H-NMR and 13C NMR spectra were acquired on a Varian INOVA 500 MHz spectrometer. 
Infrared spectroscopy (IR) was performed on a Nicolet FT-IR with a horizontal attenuated 
total reflectance (ATR) adapter plate. The polymer weights of PLA/PEG diblock 
copolymers were determined by gel permeation chromatography (GPC) versus polystyrene 
standards by an Agilent HPLC system equipped using THF as an eluent at a flow rate of 
1.0 ml min-1 through a Jordi Gel DVB Mixed Bed column at 25 °C with a refractive index 
detector. The polymer weight of alginate was determined by GPC versus dextran standards 
using aqueous buffer (0.2M NaNO3, 0.01 M phosphate buffer, pH 7.5) as the eluent at the 
rate of 0.50 ml/min through two Agilent PL aquagel columns (OH MIXED-M and OH 30, 
7.5´ 300 mm) at 25 °C with a refractive index detector. UV-Visible spectra were recorded 
on Agilent Cary 3500.  
 
2.5.3 Polymer Synthesis  
2.5.3.1 Acidic Hydrolysis of Alginate   
The acidic hydrolysis of alginate was performed according to a previous protocol with 
modification98. Briefly, sodium alginate (3 g) was added portion-wise to DI water (140 ml) 
with vigorous stirring using a mechanical stirrer. An aqueous hydrochloride acid solution 
(15.6 ml, 3M) was added and the mixture was refluxed overnight. The solution was allowed 
to cool down to the room temperature. The solid was then collected by centrifugation at 
4000 rpm for 2 min, and the supernatant liquid was discarded. The collected solid was then 
suspended in DI water (200 ml). Sodium chloride (1.2 g) was added to the aqueous solution 
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followed by the drop-wise addition of an aqueous sodium hydroxide solution (2ml, 4M). 
The pH was then adjusted to 2.3 with drop-wise addition of concentrated hydrochloric acid 
(0.8 ml, 12M). The precipitate was then collected by centrifugation at 4000 rpm for 2 min 
at room temperature, and the supernatant was decanted. The white solid was then 
suspended in 60 ml DI water, and sodium chloride (120 mg) was added to the suspension. 
The pH of the solution was adjusted to 7.5 with aqueous sodium hydroxide (4M) followed 
by the addition of active carbon (800 mg). The suspension was stirred thoroughly for 10 
min, centrifuged, and vacuum filtered to remove the activated carbon. The product was 
then precipitated with the addition of ethanol (80ml, 95%), and the white solid was 
collected by centrifugation at 4000 rpm for 2 min at room temperature, and the supernatant 
liquid was decanted. The final product was combined and freeze-dried to yield a white 
solid (1.52g,50.6% yield). The molecular weight and PDI were characterized by GPC and 
the percentage of G portion was determined by 1H-NMR. The results were summarized in 
Figure S1. 
 
2.5.3.2 tert-butyl (2-((4-(6-methyl-1,2,4,5-tetrazin-3-yl) benzyl) amino)-2-oxoethoxy) 
carbamate (tBOC-aminooxy-tetrazine) 
(Boc-aminooxy) acetic acid (71.2 mg, 0.37 mmol) and 1-[Bis(dimethylamino)methylene]-
1H-1,2,3-triazolo[4,5-b] pyridinium 3-oxide hexafluorophosphate (HATU) (171 mg,0.45 
mmol) were dissolved in 1.4 ml anhydrous DMF under argon atmosphere. The mixture 
was left to stir for ten minutes before adding (4-(6-methyl-1,2,4,5-tetrazin-3-yl) phenyl) 
methenamine hydrochloride (50 mg, 0.25 mmol) with 4 ml DMF. The mixture was let to 
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stir for another 20 minutes before adding 108 µl triethyl amine (TEA) (0.625 mmol). After 
overnight, ethyl acetate was added to the mixture so that the end volume is 50 ml. 
Extractions were done to remove DMF: 20 ml water, 3´ 20 ml 5% LiCl, 40 ml 5% LiCl, 
and 40 ml brine. The organic layer was dried with MgSO4 and evaporated to dryness. The 
product was then purified by CombiFlashÒ column chromatography system (22mg, 44.0% 
yield). 1H NMR (500 MHz, CDCl3) δ 8.79 (s, 1H), 8.54 – 8.49 (m, 2H), 7.81 (s, 1H), 7.54 
– 7.49 (m, 2 H), 4.61 (d, J = 6.1 Hz, 2 H), 4.39 (s, 2H), 3.08 (s, 3H), 1.40 (s, 9H). 13C NMR 
(126 MHz, CDCl3) δ 169.17, 166.63, 164.58, 157.05, 146.67, 130.68, 129.13, 128.08, 
83.19, 76.18, 43.15, 28.01, 22.04. LC/MS (m/z): [M+H] + calculated.  375.17 for 
[C17H22N6O4H] +, found 375.33. 
 
2.5.3.3 Alginate-oxime-tetrazine  
To generate deprotected aminooxy-tetrazine, 40 mg tBOC-aminooxy-tetrazine was 
dissolved in 2 ml hydrogen chloride solution, 4.0M in dioxane. The mixture was stirred for 
2 hours at room temperature. The pink precipitant was then collected and dried right before 
use. To synthesize tetrazine end labeled alginate, alginate (200 mg, 0.057 mmol) and 
aminooxy-tetrazine (23.5 mg, 0.085 mmol) were completely dissolved in 8 ml of acetate 
buffer solution containing 0.1M aniline (pH 4.5). After overnight, the reaction mixture was 
precipitated in ethanol three times to remove unreacted tetrazine linker followed by dialysis 
and lyophilization to obtain a pink foamy material (140.5 mg, 70.2% yield). The 
introduction of tetrazine moiety allows a direct quantification of the modification by 1H-
NMR. Integration of the two aromatic signals at 7.42 and 8.23 ppm for the tetrazine relative 
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to the protons of each repeating unit across 3.25 – 5.25 ppm reveals at least 98% coupling 
efficiency (Figure S4). The 1H-NMR (D2O, 500 MHz) with peak assignments was show in 
Figure 1. 13C NMR (D2O,101 MHz) δ 175.36, 127.94, 100.78, 80.76, 68.81, 67.00, 63.22, 
58.07, 23.11, 19.11, 13.48. IR: 3375, 1609, 1414, 1319, 1115, 1087, 1028, 949. 
 
2.5.3.4 Synthesis of TCO-PEG112-OH  
Amine-PEG112-OH (200 mg, 0.04 mmol) was reacted with (E)-cyclooct-4-en-1-yl (2,5-
dioxopyrrolidin-1-yl) carbonate (TCO-NHS) 99 in (13.89 mg, 0.052 mmol) 2ml anhydrous 
DMF with containing 56 µl triethylamine (TEA) (0.4 mmol) for 16 hours at room 
temperature. This reaction mixture was then purified by two-time diethyl ether 
precipitations followed by dialysis against methanol to remove unreacted TCO-NHS. After 
evaporation, the product was a white solid (165mg, 82.5% yield). End group conversions 
were calculated by comparing the integration from 3.5-3.75 ppm (PEG backbone) to the 
new end group integration at 5.5 ppm (strained alkene). The final end-group conversion 
was about 93%. 1H NMR (500 MHz, CDCl3) δ: 5.6-5.4 (m. 2H), 5.10 (m, 1H), 3.45-3.80 
(m, 490H), 2.31 (m,4H), 1.89 (m,2H), 1.75-1.65 (M, 2H), 1.55-1.35 (m, 2H) 13C NMR 
(101 MHz, CDCl3) δ 158.34, 137.66, 132.93, 82.94, 72.47, 70.80, 61.70, 42.38, 38.65, 
34.27, 33.14, 31.65. IR: 2881, 1712, 1466, 1343, 1276, 1241, 1147, 1103, 1060, 962, 842.  
 
2.5.3.5 Synthesis of PLA-b-PEG112-TCO 
In a typical polymerization reaction, D, L-lactide (144 mg,1 mmol) and TCO-PEG112-OH 
(100 mg, 0.02 mmol), and a stir bar were charged into scintillation vial and capped with a 
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with a rubber septum. The vial was then cycled twice with vacuum and argon at room 
temperature. Anhydrous dichloromethane was then added through syringe under argon, 
followed by sonication to ensure dissolution of all solids. 3 µl DBU (0.02 mmol) was then 
added under argon to initiate polymerization. The polymerization was then quenched after 
1h by addition of benzoic acid, followed by dialysis against methanol to remove impurities. 
After evaporation, the final product was a white solid (195 mg, 80% yield). The success of 
the polymerization was characterized by the appearance of the (-OC2H4)- region of the 
polyethylene glycol between 3.30 to 3.75 ppm and (-CH-) region of polylactide between 
5.04-5.15 ppm in 1H-NMR (Figure S8-10). The TCO functionality was also preserved and 
shown in the region between 5.40 and 5.54 ppm. 1H-NMR (500 MHz, CDCl3) and 13C-
NMR (101 MHz, CDCl3) characterizations were show from Figure S7 to S10. IR: 2961, 
2876, 1750, 1453,1343, 1214,1183, 1111, 962, 841. The GPC result of PLAn-b-PEG112-
TCO (n=50,75, and 150) was summarized in Table S1. 
 
2.5.3.6 Synthesis of Alginate-b-PEG112-b-PLA 
To improve the organic solubility of alginate-oxime-tetrazine, the alginate 
tetrabutylammonium (TBA) was formed through dialysis exchange. In a typical reaction, 
alginate-oxime-tetrazine (TBA) (50 mg, 0.014 mmol) and PLA50-b-PEG113-TCO (160 mg, 
0.0168 mmol) were dissolved in 3ml anhydrous DMF. The mixture was let to stir for 30 
minutes before it became colorless. The reaction mixture was then transferred to 
regenerated cellulose dialysis membrane (MWCO: 2000 Da) against sodium chloride 
solution, followed by lyophilization. The reaction crude was then purified by 
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dichloromethane precipitation three times to remove unreacted TCO-PEG112-b-PLA. The 
precipitant was then dissolved in water and dialysis again TBA chloride solution, followed 
by lyophilization. The final product was a white foamy solid (130 mg, 65%). The 1H-NMR 
in D2O and DMSO-d6 (500 MHz) were shown in Figure 1. FTIR: 3412, 2961, 2876,1752, 
1608, 1457, 1383, 1344, 1188, 1031, 1111.  
 
2.5.4 Preparation and Characterization of Triblock Copolymer Nanoparticles  
Nanoparticles (NPs) were prepared via modified nanoprecipitation method. 160 µl 10 mM 
BaCl2 solution was added dropwise to 24 mg of alginate-b-PEG-b-PLA triblock copolymer 
that was dissolved in 1440 µl anhydrous DMF under stirring at room temperature, followed 
by dialysis against 1L DI water overnight using a membrane (MWCO: 8000 Da) to remove 
DMF. The medium was refreshed every 3 hours.  
 
Morphologies of triblock copolymer NPs were visualized using negative stain transmission 
electron microscopy (negative stain TEM) and cryogenic transmission electron microscopy 
(cryo-TEM). For negative stain TEM, the pretreated lacy grids were applied with 5 µl 
samples and 5 µl 1% uranyl acetate. These samples were imaged using a Hitachi TH7800 
TEM. For cryo-TEM studies, a pretreated lacey grid was applied with 2 µl sample and 
plunge frozen with a Vitrobot Cryoplunger freezer. These samples were imaged using a 
FEI Tecnai Arctica Cryo-TEM with autoloader. Hydrodynamic diameter and zeta potential 
values of triblock copolymer nanoparticles were determined using NanoBrook Omni 
(Brookhaven Instruments, NY, USA). 
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2.5.5 PEG Surface Characterization  
The presence of PEG on the surface of NPs was characterized by PEGlyated protein ELISA 
assay. Briefly, PLA75-, PLA150- based triblock NPs, NH2-PEG112-OH and hydrolyzed 
alginate were diluted to the same molar concentrations in assay buffer provided by the 
manufacturer. The ELISA was run as per the manufacturer’s instructions. Optical density 
was read at 450 nm using a SpectraMax M5 Multi-Mode Plate Reader (Molecular Devices, 
San Jose, CA). In this assay, the sample competes with biotinylated PEG for binding to the 
anti-PEG antibody coated on the micro-titer plate. The signal produced is inversely 
proportional to the concentration of sample antigen. Non-sample blank (NSB) wells and 
maximum binding (B0) wells were included for calculation of percent bound of biotinylated 
PEG competitor following equation S1. 
 
Equation S1:       %"#$%& = ("#$%&'$	)*+"#$%&'$	,-.	)*)("#$%&'$	.!	)*+	0123452	,-.	)* 
 
The data were analyzed and fit to a four-parameter logistic curve using Prism 8 (Graph Pad, 
San Diego, CA). 
 
2.5.6 Encapsulation of Different Payloads into Nanoparticles  
The process for preparing drug loaded nanoparticles were similar as unloaded nanoparticles. 
Different payloads including rhodamine B, azathioprine, doxorubicin, erlotinib, irinotecan, 
and coumarin 6, was separately encapsulated into triblock copolymer nanoparticles. For 
individual loading experiment, payloads were added to DMF. The final concentrations 
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were 150 µg/ml in DMF. For rhodamine B, the loaded nanoparticles were then dialysis 
against DI water using a MWCO 8000 membrane until there is no free rhodamine B. For 
the rest of the payloads, the loaded nanoparticles were dialysis against DI water overnight 
using a membrane (MWCO: 8000 Da) to remove DMF. The medium was refreshed every 
30 minutes. The nanoparticles were then centrifuged at 17,000 g to remove un-
encapsulated molecules. As a control, drug loaded PLA75-b-PLA112 or PLA150-b-PLA112 
NPs were developed using the same formulation method.  
 
The following equations were used to calculate the drug loading efficiency (DLE): (1) DLE 
(%) = (amount of drug encapsulated in NPs/ amount of drug in feed) ´ 100%. The amount 
of loaded drug was determined for UV-Vis absorption spectra by using HPLC or 
microplate reader and calculated using a standard absorbance technique (542 nm for 
rhodamine B; 276 nm for azathioprine; 480 nm for doxorubicin; 340 nm for erlotinib; 370 
nm for irinotecan; 450 nm for coumarin 6).  
 
2.5.7 In vitro Release Studies 
In vitro release studies of different payloads from triblock copolymer nanoparticles were 
performed at 37 °C in 1´ PBS (pH 7.4) for 48 hours. Typically, 1 ml triblock copolymer 
nanoparticles loaded were transferred to dialysis units (Spectra/Por Float-A-Lyzer G2 
MWCO: 10,000 Da) from SpectrumÒ Laboratories. The dialyzer was then introduced into 
150 ml 1´ PBS (pH 7.4) medium containing 0.1% (w/w) Tween 80 to maintain sink 
condition. At predetermined time, 15 ml of the medium were taken and replenished with 
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equivalent fresh medium to maintain a sink condition. the amount of the released payload 
was then analyzed for UV-Vis absorbance using HPLC or microplate reader (542 nm for 
rhodamine B; 276 nm for azathioprine; 480 nm for doxorubicin; 340 nm for erlotinib; 370 
nm for irinotecan; 450 nm for coumarin 6). For co-release studies of rhodamine B and 
coumarin 6, azathioprine and irinotecan, doxorubicin and irinotecan from 
Alginate/PEG/PLA triblock copolymer NPs was similar as individual release study. The 
assay was performed 3 times for each time. 
 
2.5.8 Cellular Uptake in HeLa Cells  
HeLa cells were kindly provided by the laboratory of Dr. Robert Langer. Cells used were 
between passages 15 and 18. Cells were maintained in DMEM with 10% FBS in 75 cm2 
flasks and passaged every 3 days. 4.00 E5 HeLa cells were plated in 35 mm dishes 24 hours 
prior to assay start. Cells were washed once with PBS and then exposed to 1 mL of 20 
µg/mL (determined by Rhodamine concentration based on a standard curve) of either free 
rhodamine, Alginate-b-PEG112-PLA75, or Alginate-b-PEG112-PLA150 NPs.  After 3 hours, 
cells were washed twice times with PBS 0.05% Tween-20 and incubated with 1 mL of 
staining solution (1:1000 CellMask Deep Red Plasma membrane stain and 1:2000 Hoechst 
3342 in PBS) for 10 minutes at room temperature. Cells were washed thrice with PBS and 
then incubated with 1 mL of 2% formaldehyde for 10 minutes at room temperature. Last, 
cells were washed twice with 1 mL of PBS and left at 4ºC until imaging. Confocal 
microscopy was performed on an Olympus FV10i and images were processed using FIJI. 
 
Flow cytometry experiments were performed following a similar protocol. 24 hours prior 
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to assay start, 4.00 E5 HeLa cells were plated in each well of a 6 well plate. Cells were 
then incubated with 1 mL of 20 µg/mL of free rhodamine or rhodamine encapsulated 
nanoparticles for 3 hours at 37ºC/5% CO2. All treatments were performed in triplicate. 
Cells were then washed three times with PBS 0.05% Tween-20, trypsinized, spun down at 
150g for 5 minutes, and then fixed in 2% formaldehyde on ice for 30 minutes. Cells were 
spun down at 400g for 5 minutes, rinsed with 1 mL of FACS buffer (2 mM EDTA 0.1% 
BSA in PBS) and spun down again. Finally, cells were resuspended in 500 µL of FACS 
buffer and strained through the 35 mm nylon strainer cap on BD 12 x 75 mm tubes. Flow 
analysis was performed on a BD FACS Calibur and data was processed using FlowJo. 
Gating (Figure SX) was first performed based on side and forward scatter to exclude 
cellular debris and doublet events. Gating for fluorescence was based on background on 
FL2 (emission = 585 nm) acquired by untreated HeLa cells. Cells in Q3 were deemed as 
fully labeled and used to calculate percentage of cells labeled in Figure 5. Data were plotted 
and analyzed using GraphPad Prism 8. 
 
2.5.9 Cell Viability of Triblock Copolymer and Nanoparticles  
NIH-3T3 cells were a gift from Dr. Xin Brown at Boston University and maintained in 
high DMEM with 10% FBS. Formulated NPs and lyophilized triblock copolymer were 
dissolved in 1´ PBS (pH 7.4). 5X solutions of NPs or polymer for assays were made by 
diluting stock solutions into DMEM. 10,000 cells were plated into each well of a white, 
opaque bottom 96 well plate 24 hours before assay start. Cell culture media was aspirated 
and 80 µL of fresh DMEM was added to each well followed by 20 µL of 5X NPs or 
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polymer solution. Untreated cells were used as a positive control and DMSO treated cells 
were included as a negative control. Plates were incubated for 24 hours at 37ºC/5% CO2 
followed by cell quantification with CellTiter-Glo 2.0. Plates were incubated with reagent 
for 10 minutes at room temperature followed by luminescence reading using a Molecular 
Devices SpectraMax M5 plate reader. Percent viability was calculated by subtracting 
background RLU and normalizing to RLU from untreated cells. Each measurement was 




Chapter 3 Development and Characterization Alginate/PLA Chimeras Hydrogels 
with Tunable Degradation  
3.1 Abstract   
 
This chapter focuses on the synthesis and fabrication of alginate/PLA-based degradable 
hydrogels. The chapter starts with detailed synthesis and characterization of alginate-b-
PLA diblock copolymer by covalently attachment of alginate with polylactide (PLA) using 
an inverse electron demand Diels-Alder reaction. Next, alginate/PLA diblock copolymers 
formed hydrogels by two fabrication methods: doping and direct gelation. The resulting 
hydrogels were subsequently characterized by Young’s modulus and porosity. The 
degradation profiles were measured by their swelling ratio and were tunable from days to 
weeks by changing the blending ratio. The decline in mechanical properties of 
alginate/PLA hydrogels starts during the swelling equilibrium phase followed by the 
degradation of the matrix by hydrolysis of the PLA domain. Lastly, the release studies of 
four different payloads with different hydrophobicities and molecular weights suggests the 
release mechanism of cargo molecules is independent from the degradation of the 














3.2 Background  
 
Hydrogels are insoluble three-dimensional networks formed by hydrophilic polymers, 
which contains a high water content similar to native tissues100. Hydrogels have various 
biomedical applications such as drug delivery, tissue engineering scaffolds, wound 
dressings, and vaccines. In particular, alginate is a naturally anionic polysaccharide 
consisting of b-D- mannuronic acid (M) and a-L-guluronic acid (G) isomeric monomers. 
Alginate has been widely used in drug delivery78 and cell therapy77 due to its 
biocompatibility, low toxicity, and facile gelation in the presence of divalent ions such as 
Ca2+ and Ba2+. However, the degradation of alginate is a slow and uncontrollable process, 
and it typically requires removal from the implantation sites since there are no enzymes 
that can naturally degrade alginate in mammals101.  
 
In the past decades, several strategies have been introduced to develop degradable alginate 
hydrogel systems. For example, the degradation kinetics of alginate hydrogels can be 
controlled by partial oxidation of the alginate backbone to create acetal groups vulnerable 
to hydrolysis combined with a bimodal molecular weight (MW) distribution where high 
molecular weight (HMW) and low molecular weight (LMW) alginate were mixed 
together102. Although it was found that the partially oxidized alginate degraded faster than 
unmodified controls, there was limited degradation tunability when comparing HMW 
alginate and bimodal MW groups. A second strategy is to form alginate hydrogel via 
covalent cross-linking in replacement with facile ionic gelation. Different degradation 
modes including hydrolysis98, enzymatic cleavage103, and external user input such as 
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light104 can be incorporated by varying the linker moieties. However, those strategies are 
not all biological inert 105 and optimal for cell and protein encapsulation due to the cross-
reactivity of common functional groups presented in cells and proteins. Moreover, it is also 
difficult to compare hydrogels between divalent ions and covalent crosslinkers since the 
mechanical properties of alginate hydrogels varied by changing the density and length of 
the crosslinker 106. A third fabrication strategy is to develop alginate scaffold loaded with 
an alginate lyase, an enzyme which digests alginate chain crosslinked with calcium or 
barium. Silva and co-workers developed alginate hydrogels incorporating alginate lyase 
loaded poly (lactide-co-glycolide) microspheres107. It was observed that the degradation of 
hydrogel can be tuned by controlling the concentration of lyase and neural progenitor cells 
(NPCs) were cultured and proliferated inside the scaffolds. Similarly, injectable alginate 
hydrogels containing alginate lyase were found to increase endothelial progenitor cells 
migration and functional vasculature in vivo108.  However, the higher lyase concentration 
also resulted in weaker hydrogel mechanical properties.  The relationship between 
concentration of alginate lyase has to be more closely examined for other tissue engineering 
applications since the influence of lyase concentration on cell viability was dependent on 
the cell lines.  
 
Here, we present an alternative approach to develop degradable alginate-based hydrogels 
which, in subsequent, can be used as scaffolds in drug delivery and tissue engineering. 
Degradation is a key factor in this study as degradation permits cell proliferation, migration, 
infiltration of new blood vessels, and matrix remodeling in tissue engineering109–111. It also 
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enables spatiotemporal release of cargos in drug delivery112–114. The degradation mode of 
choice is hydrolysis due to its facile implementation and passive reaction mechanism upon 
contacting with water-based aqueous solutions. Polylactic acid (PLA) is one of the most 
widely used synthetic polymers due to its biocompatibility, tailored properties, and well-
established formulations82. Due to the presence of an ester linkage, the water can easily 
hydrolyze the PLA backbone without addition of enzymes. It leads us to hypothesize that 
incorporation of PLA domain can impart susceptibility of hydrolytic degradation to the 
alginate hydrogels. The degradation can then be tuned by varying the size of both polymer 
domains as well as fabrication methods.  
 
Here, we engineer an alginate-based hydrogel with tunable degradation. In order to achieve 
this goal, alginate and PLA were tethered into a single macromolecule utilizing an inverse 
electron demand Diels-Alder reaction, which also preserves the carboxylic groups 
responsible for gelation properties. The resulting diblock copolymers were then thoroughly 
characterized by nuclear magnetic resonance (NMR), FTIR, and UV-Vis spectrometry. 
Two different strategies were used to fabricate the alginate/PLA chimeras hydrogels.  The 
degradation behaviors were measured by tracking swelling ratio, rheological measurement 
and the final degradation products were characterized by 1H-NMR. We showed that the 
degradation time of the alginate/PLA-based hydrogels can be tuned from days to weeks by 
modulating the size of PLA domain as well as fabrication methods. Finally, to determine 
the potential of degradable alginate/PLA hydrogels as drug delivery systems, four different 
payloads were encapsulated into the scaffolds. Our studies suggested the release of payload 
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was mediated by diffusive mechanism but not dependence on the degradation of the 
alginate hydrogels. In the future, we envision to synthesize a fluorescent probe labelled 
alginate-b-PLA to better understand the degradation process and explore the potential of 
degradable alginate/PLA scaffolds in tissue engineering where the influence of scaffold 





3.3 Results  
 
3.3.1 Alginate-b-PLA Synthesis  
 
 
Scheme 3. 1. Synthetic scheme of alginate-b-PLA. The ligation between alginate and PLA is 
mediated by inverse electron-demand Diels-Alder reaction between tetrazine and trans-cyclooctene 
(TCO).  
  
To synthesize alginate-b-PLA diblock copolymers, alginate-tetrazine is ligated with the 
PLA-TCO (Scheme 3.1). However, one major challenge is the solubility difference of 
these two macromolecules in organic solvents: sodium alginate is only water soluble while 
the PLA-TCO can be dissolved in non-polar organic solvents. To improve the organic 












































salt through ion exchange. The resulting TBA-alginate-tetrazine salt was readily 
solubilized in aprotic solvent such as DMF or DMSO and readily ligated for the 
Alginate/PLA chimaeras synthesis. The final diblock copolymers were characterized by 





Figure 3. 1. The 1H-NMR characterization of alginate-b-PLA: (A) alginate4K-b-PLA and (B) 
alginate31K-b-PLA (D2O, 500 MHz). The alginate backbone is indicated in the red box and full 
consumption of tetrazine and TCO was observed.   
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When dissolving in D2O, the characteristic peaks of PLA were not observed in both 
Alginate31K and Alginate4K- based diblock copolymers, only peaks consistent with the 
alginate backbone. The loss of proton signals from the polylactide in D2O indicated that 
the diblock copolymer exhibited potential hydrophobic aggregation in solution (Figure 
3.1). The 1H-NMR of the diblock in DMSO-d6 revealed specific peaks corresponding to 
the methyl (-CH3) and -CH- groups of the polylactide backbone at 5.10 ppm and 1.40 ppm. 
In DMSO-d6, the characteristic peaks of alginate were not observed, consistent with 
aggregation of these hydrophilic domains of the polymer (Figure 3.2). Diagnostic peaks 
for tetrazine (7.42 and 8.23 ppm) from the alginate-tetrazine and TCO functionalities from 
the diblock (5.40 and 5.54 ppm) disappeared after conjugation according to 1H-NMR 








Figure 3. 2. 1H-NMR characterization of alginate-b-PLA: (A) alginate4K-b-PLA and (B) 
alginate31K-b-PLA (DMSO-d6, 500 MHz). The full consumption of tetrazine and TCO was 
observed. Peaks marked with * are tetrabutylammonium peaks. The designated peaks for PLA 




Figure 3. 3. FTIR characterization of alginate-b-PLA diblock copolymers: (A) PLA and signature 
peaks were marked on the spectrum. (B) alginate-oxime-tetrazine and signature peaks were marked 
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on the spectrum. (C) alginate4K-b-PLA and signature peaks were marked on the spectrum. (D) 
alginate31K-b-PLA and signature peaks were marked on the spectrum. 
 
FTIR analysis showed the anticipated stretching vibrations of OH groups from alginate at 
3375 cm-1, as well as the asymmetric and symmetric stretches of the C=O from the 
carboxylate appeared in 1608 and 1418 cm-1 (Figure 3.3). The stretching of C=O from the 
polylactide was identified at 1752 cm-1 along with -CH stretching at 2961 cm-1. For UV-
Vis spectrum, the signature of alginate-oxime-tetrazine at 525 nm disappeared after 
conjugated with PLA-TCO indicating the full consumption of tetrazine functionality 
(Figure 3.4) in both cases. Taken together, these characterizations confirmed the synthesis 





Figure 3. 4. UV-Vis spectra of (A) alginate4K-oxime-tetrazine and alginate4K-b-PLA and (B) 




3.3.2 Fabrication and Characterizations of Alginate-b-PLA Chimeras Hydrogels  
 
 
Figure 3. 5. The graphic illustration of fabrication strategies for alginate-b-PLA chimaeras 
hydrogel. Doping strategy: alginate4K-b-PLA is blended with low viscosity alginate (LVA), which 
acts as major structural scaffold. The hydrogel is formed in the presence of barium chloride. Direct 
gelation: alginate31K-b-PLA diblock copolymer forms hydrogel directly in the presence of barium 
chloride without additional blending biomaterial. 
Two different strategies were implemented to fabricate alginate-b-PLA chimeras hydrogels 
(Figure 3.5). Based on our preliminary studies, alginate4K-b-PLA diblock copolymers were 
not able to form hydrogel in the presence of divalent ion (barium chloride) due to the small 
size of the alginate domain (data not shown). Therefore, small MW alginate4K/PLA diblock 
copolymers were doped into low viscosity alginate (LVA), which acts as the major scaffold 
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to form the hydrogel with barium chloride. Different blending ratios between LVA and 
alginate4K-b-PLA were also used when preparing the hydrogels. In contrast, alginate31K-b-
PLA chimeras was able to form the hydrogel directly with barium chloride when preparing 
at 5% solution.  
 
The porosity (%) and Young’s modulus were used as two major parameters to characterize 
alginate-b-PLA chimeras hydrogels. When the blending ratio is below or equal to 3:1, the 
porosity of LVA/alginate4K-PLA hydrogels is between 50-60%. When the blending ratio 
is larger than 3:1, the porosity is around 20%. The decline in porosity of LVA/alginate4K-
b-PLA might result from the increase the weight percent of LVA, which then formed a 
denser network when crosslinked with barium chloride (Figure 3.6).  
 
As shown in Figure 3.7F, the Young’s modulus of alginate31K hydrogel control is 11.4- 
and 27.8- fold higher than alginate31K-b-PLA2K and alginate31K-b-PLA10K chimeras 
hydrogels respectively (p<0.05). Those results indicated that end conjugation of PLA 
domain to Alginate31K has a negative effect on the mechanical stability of the hydrogels. 
For LVA/alginate4K-b-PLA system, the influence of different blending ratio between LVA 
and alginate/PLA diblock copolymer on the Young’s modulus was investigated (Figure 
3.7 A-E). In general, the Young’s modulus of alginate4K controls is 1.18-2.74 fold higher 
compared to alginate4K/PLA2K-based chimeras hydrogels and 1.36-4.9 fold higher than 
alginate4K/PLA10K-based system when blending ratio ranging from 1:1 to 49:1. Although 
there was no statistically significant difference between alginate4K and alginate4K-b-
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PLA10K for a blending ratio 19:1, there is a negative correlation between mechanical 
stability of LVA/alginate-b-PLA hydrogels and molecular weight of PLA domains for 
doping strategy.  
 
 
Figure 3. 6. Porosity characterization of alginate-b-PLA alginate. (A) Porosity measurement of 
LVA/alginate4K-b-PLA hydrogels with blending ratio from 1:1 to 49:1. (B) Porosity measurement 






Figure 3. 7. Mechanical characterization of alginate-b-PLA chimeras hydrogels measured by 
Young’s modulus: (A) LVA/ alginate4K-b-PLA (1:1). (B) LVA/ alginate4K-b-PLA (3:1). (C) LVA/ 
alginate4K-b-PLA (9:1). (D) LVA/ alginate4K-b-PLA (19:1). (E) LVA/ alginate4K-b-PLA (49:1). (F) 
Alginate31K-b-PLA hydrogels. In all cases, data are represented as mean ± SD (n=3). For statistical 
analysis, ns : p > 0.05, *: p < 0.05, and ** <  0.01.  
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3.3.3 Degradation of Alginate-b-PLA Chimeras Hydrogels  
The degradation behaviors of LVA/alginate4K-b-PLA blending hydrogels and alginate31K-
b-PLA chimeras hydrogels were tracked by measuring their swelling ratios immersed in 
PBS buffer at 37°C. Typically, the hydrogels reached equilibrium rate within 4 hours and 
remained at equilibrium before degradation occurred. It is also notable that the swelling 
ratio of alginate/PLA diblock copolymer hydrogels is higher than its corresponding 
alginate hydrogel control for both doping except for the LVA/alginate4K-b-PLA (49:1). The 
increase in swelling ratios for alginate/PLA based hydrogels indicated the diblock 
copolymer exhibited potential hydrophobic aggregation during the gelation process, which 
then disrupted the crosslinking interaction between alginate and barium chloride.  For 
doping strategy, to demonstrate the tunability of this system, the mass ratio between LVA 
and alginate4K-b-PLA (blending ratio) was varied from 1:1 to 49:1 and the degradation 
time of blended hydrogels can be modulated from days to weeks. In contrast, the alginate4K 
hydrogel controls remains relatively stable within the same time frame. For example, when 
blending ratio is 3:1, the alginate4K-b-PLA10K blended hydrogel degraded within 50 hours 
and alginate4K/PLA10K -based blended hydrogel disappeared within 80 hours. When 
increasing the blending ratio 49:1, the degradation duration for LVA/alginate4K-b-PLA 
blending hydrogels increased to 2 weeks (~ 350 hours). Meanwhile, the degradation time 
difference between PLA2K- and PLA10K- based hydrogels is more pronounced at lower 
blending ratios. For example, the degradation time difference is 1.3 for blending ratio 1:1 
and 1.7 for blending ratio 3:1. Such difference indicated the influence of the molecular 
weight of PLA on the hydrogel degradation for lower blending ratios. However, such 
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difference gradually diminishes to 1.0 when the blending ratio was increased to 49:1, which 
can be explained by the dilution effect of LVA in the blending system. Similarly, when 
conjugating PLA domain directly to the reducing end of alginate31K polymer, the 
alginate31K/PLA-based hydrogel exhibited degradation behavior where the swelling ratio 
substantially decreased within 250 hrs.  
 
 
Figure 3. 8. The degradation profile of LVA/alginate4K-b-PLA (1:1) hydrogels measured by 




Figure 3. 9. The photographic illustration of degradation of the LVA/alginate4K-b-PLA (1:1) 





Figure 3. 10. The degradation profile of LVA/alginate4K-b-PLA (3:1) hydrogels measured by 




Figure 3. 11. The photographic illustration of degradation of the LVA/alginate4K-b-PLA (3:1) 





Figure 3. 12. The degradation profile of LVA/alginate4K-b-PLA (9:1) hydrogels measured by 




Figure 3. 13. The photographic illustration of degradation of the LVA/alginate4K-b-PLA (9:1) 





Figure 3. 14. The degradation profile of LVA/alginate4K-b-PLA (19:1) hydrogels measured by 




Figure 3. 15. The photographic illustration of degradation of the LVA/alginate4K-b-PLA (19:1) 





Figure 3. 16. The degradation profile of LVA/alginate4K-b-PLA (49:1) hydrogels measured by 





Figure 3. 17. The photographic illustration of degradation of the LVA/alginate4K-b-PLA (49:1) 





Figure 3. 18. The degradation profile of alginate31K-b-PLA hydrogels measured by swelling ratio 





Figure 3. 19. The photographic illustration of degradation of the alginate31K-b-PLA hydrogels at 
pre-determined time points.  
3.3.4 Alginate-b-PLA Hydrogel Degradation Monitored by Rheological Measurements 
and 1H-NMR  
To attain a more thorough understanding of the degradation of the alginate-b-PLA 
chimeras hydrogels, LVA/alginate4K-b-PLA (3:1) and alginate31K-b-PLA hydrogels were 
selected as model systems. The degradation process was then monitored by a series of 
rheological measurements and the final degradation products were characterized by 1H-
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NMR. For rheological measurements, the storage modulus (G’) of LVA/alginate4K-b-
PLA2K was lost by 30% within 24 hours, and the number was increased to 54% by 48 hours 
compared to its initial value (Figure 3.20 B). However, the swelling ratio of the hydrogel 
was relatively static during the same period of time. Similarly, for LVA/alginate4K-b-
PLA10K hydrogel, the storage modulus (G’) lost by 54.4% within 24 hours and 76% by 48 
hours (Figures 3.20 B). For alginate31K-b-PLA chimeras hydrogel, the storage modulus 
(G’) lost by 51.3% and 56.3% for PLA2K and PLA10K respectively within 110 hours 
(Figure 3.20 E and F) although the swelling ratio remained relatively stable (Figure 3.18).  
Furthermore, the PBS medium was collected for 1H-NMR after degradation studies. The 
peaks associated with free lactide were identified in both the degraded LVA/alginate4K-b-
PLA and alginate31K-b-PLA hydrogels (Figure 3.21), further confirming that degradation 
of the hydrogel was linked to PLA domain hydrolysis.  
 
Taken together, all these results suggest that the hydrogels started to lose their mechanical 
stability from swelling equilibrium phase. The results also support the hypothesis that the 
degradation nature of alginate/PLA-based chimeras hydrogels fabricated by doping and 






Figure 3. 20. Degradation process of alginate/PLA-based chimeras hydrogels characterized by 
rheological measurements: (A) LVA/alginate4K (3:1) (B) LVA/alginate4K-b-PLA2K (3:1) (C) 
LVA/alginate4K-b-PLA10K (3:1) (D) alginate31K (E) alginate31K-b-PLA2K (F) alginate31K-b-PLA10K. 






Figure 3. 21. 1H-NMR characterizations of degradation products of alginate/PLA-based chimeras 
hydrogels and peak associated with PLA is marked with red box: (A) Graphic representation of 





3.3.5 Payload Release from Alginate-b-PLA Chimeras Hydrogel  
Four different compounds were encapsulated into degradable hydrogels to test their 
potentials as drug delivery systems. The LVA/alginate-b-PLA (3:1) blended hydrogels 
were used as model systems. To investigate their capability to encapsulate and release 
diverse molecules, hydrogels were loaded with small molecules with different 
hydrophobicities: (A) azathioprine, an immunosuppressive agent with a log P of 0.1, (B) 
doxorubicin hydrochloride, a chemotherapeutic drug with a log P of 0.53, (C) coumarin 6, 
a fluorescent dye with a log P of 4.79. Albumin-FITC was also encapsulated into hydrogel 
to investigate the influence of molecular weight on the release behavior. In general, for 
each payload, there was no difference between alginate4K control and alginate/PLA diblock 
copolymer-based hydrogels in which all three hydrogel formulations released individual 
payloads at a consistent rate. Notably, the higher released percentage of coumarin 6 (~ 60% 
within 100 hours) was potentially resulted from the low loading level and the addition of 
Tween 20 (0.1%) in the 1´ PBS to create the sink condition due to its high log P value.  
 
Previous studies showed that the release kinetics of encapsulated payload from hydrogels 
is dictated by the relative size of cargo and the mesh size of the hydrogel115.  When the 
mesh size of the hydrogel is smaller than the hydrodynamic radius of payload, the release 
kinetics is dependent on the degradation of hydrogel. On the other hand, smaller cargo 
molecule relies on the diffusive mechanism. Our release result suggests that the payload 
size is relatively smaller than the mesh size of the hydrogel. In consequence, the release 
behavior of alginate/PLA-based hydrogels is mainly mediated on the diffusive mechanism 
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but not dependent on the degradation of the alginate/PLA-based hydrogels. In the future, 
several strategies can be explored to understand the degradation of PLA domain on the 
release of encapsulated cargo. For example. Silva and co-workers encapsulated lentivector 
(LV) and adeno-associated vectors (AAV) into degradable alginate hydrogels. It was found 
that the release of LV particles relied on the degradation of hydrogel but AAV particles did 
not due to the fact that the hydrodynamic radius of LV is around 166 nm but the AAV is 
around 29 nm116. Another way is to increase the concentration of barium chloride or 







Figure 3. 22. Payload release from LVA/alginte4K-b-PLA blended hydrogels: (A) Azathioprine (B) 





3.4 Discussion  
 
In this study, we have demonstrated the synthesis of a novel alginate/PLA-based diblock 
copolymer with an inverse electron-demand Diels-Alder reaction. Although PLA grafted 
polysaccharides have been synthesized and characterized in the past117–119, this is the first 
report to develop polysaccharide-b-PLA block copolymer. The resulting diblock 
copolymers can be fabricated into hydrogels using two readily implemented strategies: 
doping distribution for alginate4K/PLA and direct gelation for alginate31K/PLA diblock 
copolymers. For doping strategy, the blending ratio between high and low MW alginate 
plays an important role to modulate the degradation profile of hydrogels. We have shown 
that the degradation time can be tuned from within 4 days when the blending ratio between 
LVA (high MW) and alginate4K-b-PLA is 3:1 to 2 weeks when there is only 2% of 
alginate4K-b-PLA in the whole material system. For direction gelation, the swelling ratio 
of both alginate31K/PLA2K and alginate31K/PLA2K-based polymer chimeras hydrogel 
significantly decreased within 10 days in a similar rate. The controlled and tunable 
degradation of the LVA/alginate4K-b-PLA material system makes it an attractive platform 
to fabricate degradable alginate hydrogels.  
 
To better understand the degradation mechanism of alginate/PLA chimera hydrogel, we 
used rheological measurement to study how mechanical properties exhibited during 
degradation studies and NMR characterization to study the final degradation products. 
There was a steep decline for storage modulus (G’) for both LVA/alginate4K-b-PLA and 
alginate31K-b-PLA hydrogels during swelling equilibrium stage compared to alginate 
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controls (Figure 3.20). This dramatic decrease in mechanical properties from swelling 
equilibrium phase suggests the rheological measurement is a more sensitive method than 
swelling ratio when characterizing degradation. Similarly, Grover and co-workers used 
rheological measurement to track the mechanical properties of fibroblasts-encapsulated 
alginate hydrogel and it was found that the alginate degradation occurred throughout the 
study but was greatest within the first week120. Meanwhile, the 1H-NMR characterizations 
showed signature peaks associated with PLA in the PBS medium during degradation. 
Although studies have shown the alginate hydrogel degrades over time with ionic 
dissipation between calcium or barium and surrounding monovalent ions such as sodium 
and potassium121, rheological and NMR results support the hypothesis that the decline in 
mechanical properties of alginate/PLA hydrogels is resulted from the hydrolytic 
degradation imparted from the PLA domain considering both alginate controls and 
alginate/PLA chimera hydrogels were both formed by ionic gelation. In the future, 
fluorescent probe (TAMRA) end labelled alginate/PLA diblock copolymer will be 
synthesized and characterized. Fluorophore labeling strategy has been reported before to 
monitor hydrogel degradation non-invasively for different tissue engineering 
applications122,123.The attaching fluorophore will enable us to image the degradation 
process using confocal microscopy and quantify the degradation by directly measuring the 
cleavage of the fluorescent probe using microplate reader. Taken together, it will provide 





Hydrogels are also attractive candidates to study cell behaviors by mimicking native 
microenvironment124,125 and serving as depots to deliver various cargos such as growth 
factors126 , cytokines127, and genes128. The degradable hydrogels have shown to promote 
vascularization129, support cell proliferation111, and enhance tissue regeneration130. 
Therefore, we envision the alginate/PLA chimera hydrogels with tunable degradation can 
serve as attractive platform for tissue engineering applications in the future.  
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3.5 Materials and Methods  
 
3.5.1 Chemicals  
Alginate (Pronova UPVLVG, Mn=31,000) was purchased from Novamatrix (Sandvika, 
Norway).    Low viscosity alginate (LWA) was obtained from MP Biomedicals (OH, USA) 
(4-(6-methyl-1,2,4,5-tetrazin-3-yl) phenyl) methanamine was purchased from Click 
Chemistry Tools (AZ, USA). tBOC-aminooxy acetic acid, 1-
[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium3-oxide 
hexafluorophosphate (HATU), barium chloride (anhydrous), and solvents were purchased 
from Thermo Fisher Scientific (MA, USA). D-mannitol, triethylamine, hydrogen chloride 
solution, 4M in dioxane, was purchased from Sigma-Aldrich (MP, USA). a-amine-w-
hydroxyl poly (L-Lactide) (PLA-NH2, MW= 2K, 10K, and 20K g/mol) was purchased 
from NanoSoft Polymers (NC, USA). Spectra/PorÒ 7 dialysis membrane (MWCO: 
2000/8000 Da) was purchased from Repligen (MA, USA).  
 
3.5.2 Characterizations  
1H-NMR and 13C NMR spectra were acquired on a Varian INOVA 500 MHz spectrometer. 
Infrared spectroscopy (IR) was performed on a Nicolet FT-IR with a horizontal attenuated 
total reflectance (ATR) adapter plate. The polymer weight of alginate was determined by 
GPC versus dextran standards using aqueous buffer (0.2M NaNO3, 0.01 M phosphate 
buffer, pH 7.5) as the eluent at the rate of 0.50 ml/min through two Agilent PL aquagel 
columns (OH MIXED-M and OH 30, 7.5´ 300 mm) at 25 °C with a refractive index 
detector. UV-Visible spectra were recorded on Agilent Cary 3500. 
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3.5.3 Synthesis of Alginate-b-PLA  
To improve the organic solubility of alginate-oxime-tetrazine, the alginate 
tetrabutylammonium (TBA) was formed through dialysis exchange. In a typical reaction, 
alginate4K-oxime-tetrazine (TBA) (50 mg, 0.01 mmol) and PLA10K-TCO (150 mg, 0.015 
mmol) were dissolved in 2 ml DMSO/DCM mixture (volume ratio: 5:1). The reaction 
mixture was let to stir for overnight before it became colorless. The mixture was then 
transfer to regenerated cellulose dialysis membrane (MWCO: 8000 Da) against sodium 
chloride solution, followed by lyophilization. The reaction crude was then purified by 
dichloromethane precipitation three times to remove unreacted PLA-TCO. The precipitant 
was then dissolved in water and dialysis against sodium chloride solution, followed by 
lyophilization. The final product was a white foamy solid (130 mg, 65%). The synthesis of 
rest of alginate-b-PLA diblock copolymer followed similar protocol. The 1H-NMR, FTIR, 
and UV-Vis spectrometry characterized are summarized from Figure 3.1 to Figure 3.3.   
 
3.5.4 Fabrication of Alginate/PLA Diblock Copolymer-based Hydrogels  
For Alginate31K-b-PLAn (n=2000 and 10,000 g/mol), diblock copolymer was dissolved at 
5wt% in DI water and mixed for 2 min under sonication. Samples were then centrifuged at 
37℃, 4000 rpm for 20 min to remove trapped air bubble. 150 µl diblock copolymer solution 
was then poured into 2ml syringe and crosslinked by 150 µl 150 mM BaCl2 solution / D-
mannitol solution (volume ratio= 1:1) for 30 min to produce a cylindrical sample with 8mm 




For Alginate4K-b-PLAn (n=2000 and 10,000 g/mol), the final concentration of the 
LVA/Alginate4K-b-PLAn blended solution was at 2 wt% and the ratio of LVA and 
alginate4K-b-PLA was varied from 1:1. 3:1, 9:1, 19:1, and 49:1. Similarly, samples were 
then centrifuged at 37℃, 4000 rpm for 20 min to remove trapped air bubble. 150 µl blended 
polymer solution was then poured into 2ml syringe and crosslinked by 150 µl 150 mM 
BaCl2 / D-mannitol solution (volume ratio= 1:1) for 30 min to produce a cylindrical sample 
with 8mm diameter and 2mm thickness. 
 
3.5.5 Porosity Measurement of Alginate-b-PLA Chimeras Hydrogels 
The solvent replacement method was used for porosity measurements. Each alginate/PLA 
chimera and alginate hydrogel controls were first lyophilized and dry weight (Wi) of each 
sample was measured. The test samples were then immersed in absolute ethanol for 3 days 
and weight immediately (Wf) after excess ethanol on the surface of the hydrogel was 
removed by Kimtech wipes. The porosity (%) was calculated as (Wf - Wi)/(V×ρ)) × 100, 
where V is the volume of the hydrogel disk and ρ is the density of absolute ethanol. Results 
were averaged on three independent runs. 
 
3.5.6 Compressive Mechanical Properties of Alginate-b-PLA Chimeras Hydrogels  
The compressive mechanical properties of alginate chimeric hydrogels were evaluated on 
a DHR-2 hybrid rheometer (TA Instrument, MA, USA) at room temperature. Cylindrical 
samples were compressed until 70% strain. During the test, the compressing rate was set 
as 10µm/s and stress-strain curves were recorded. The Young’s modulus was calculated 
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from the linear part at the beginning of the stress-strain-curve regarding Hooke’s law. Each 
measurement was performed in triplicate.  
 
3.5.7 Degradation of Alginate-b-PLA Polymer Chimeras Hydrogels 
The degradation tests were performed by incubating the pre-weighted lyophilized hydrogel 
samples in 5ml 1´ PBS buffer at 37℃. At predetermined time intervals, the samples were 
removed from solution and placed on a glass slide to remove the excess water on the sample 
surface wiped by KimTech wipers. Each degradation study was performed in three time. 
The degradation profiles were assessed by measuring the swelling ratio (SR) defined by 
SR = 67+6868   where Wt and W0 are the weights of the swollen samples at a particular time 
interval t and weights of lyophilized samples, respectively.  
 
3.5.8 Hydrogel Degradation Monitored by Rheological Measurement   
Alginate31K-b-PLAn and LVA/alginate4K-b-PLAn (3:1) were chosen model hydrogels to 
determine rheological properties change during degradation. Briefly, at pre-determined 
time points, storage modulus (G′) and loss modulus (G′′) were measured with a DHR-2 
hybrid rheometer (TA Instrument, MA, USA) equipped with an 8 mm diameter parallel 
Peltier Plate geometry at room temperature. First, viscoelastic linear regime was 
determined by oscillatory strain sweep test at a frequency of 10rad/s. Then, the storage 
modulus (G’) and loss modulus (G”) of hydrogels were characterized as a function of 
frequency at 0.05% strain set based on viscoelastic linear regime. Each measurement was 
performed in triplicate. 
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3.5.9 Hydrogel Degradation Characterized by 1H-NMR  
Alginate31K-b-PLAn and LVA/Alginate4K-b-PLAn (3:1) were chosen as model hydrogels 
to analyze final degradation product by 1H-NMR. Briefly, the degradation tests were 
performed by incubating the pre-weighted lyophilized hydrogel samples in 5ml 1´ PBS 
buffer at 37℃. Towards the end of hydrogel degradation studies, 1´ PBS buffers were 
collected. After lyophilization, the samples were washed 3 times with dichloromethane to 
exact degradation products and characterized by 1H-NMR after vacuum dry. 
 
3.5.10 Payload Release from Alginate-b-PLA Chimeras Hydrogels  
For Alginate4K-b-PLAn (n=2000 and 10,000 g/mol), the final concentration of the 
LVA/Alginate4K-b-PLAn blended solution was at 2 wt% and the ratio of LVA and 
alginate4K-b-PLA was 3:1. For azathioprine, doxorubicin hydrochloride and albumin-FTIC, 
300 µg each payload was mixed with 150 µl blended polymer solution before pouring into 
2ml syringe and crosslinked by 150 µl 150 mM BaCl2 / D-mannitol solution (volume ratio= 
1:1) for 30 min to produce a cylindrical sample with 8mm diameter and 2mm thickness. 
For coumarin 6, only 30 µg was encapsulated into the hydrogel. The samples were then 
immersed in 8ml 1´ PBS buffer at 37℃. At predetermined time intervals, 5ml 1´ PBS 
buffer was removed and replenished with equivalent fresh medium to maintain a sink 
condition. For coumarin 6, 1´ PBS buffer containing 0.1% Tween 80 was used due to its 
high hydrophobicity. The amount of the released payload was then analyzed for UV-Vis 
absorbance using HPLC or microplate reader after lyophilization (276 nm for azathioprine, 
  
 100 
480 nm for doxorubicin hydrochloride, 450 nm for coumarin 6, and 490 nm for albumin-





Chapter 4 Proteomics-based Method to Understand the In-Vivo Fate of Chiral Poly 
(L-lactide)-b-Poly (amido saccharide) (PLLA-b-PAS) Nanoparticles   
4.1 Abstract   
 
This chapter focuses on the understanding of potential in-vivo fate of novel poly (L-
lactide)-b-poly (amido saccharide) (PLLA-b-PAS) chiral nanoparticles (NPs). The chapter 
starts with detailed synthesis and characterization of PLLA-b-PAS diblock copolymer 
using an electron inverse demand Diels Alder reaction. Next, the combination of a 
hydrophobic PLA and hydrophilic PAS result in an amphiphilic diblock copolymer that 
self-assembles under aqueous conditions. The resulting chiral nanoparticles have a 
diamond-like structure with ~ 100 nm in diameter. Lastly, these chiral NPs were incubated 
with mouse serum and the composition of adsorbed protein corona was analyzed by LC-
MS/MS-based proteomics. The studies will build a foundation to future advance the 
understanding of in-vivo fate of PLLA-b-PAS NPs, the influence of surface chirality on 




4.2 Background  
 
Upon entering the bloodstream, the surface of nanoparticles (NPs) adsorbs various of 
serum proteins rapidly (within 30 seconds)131. The adsorbed protein layer is known as the 
“protein corona”. Initially, the “soft” corona is formed when the proteins with high-
abundance and high-mobility are attached to the surface of the NPs. Overtime, a “hard” 
corona composed of lower-mobility and higher-binding affinity proteins such as 
immunoglobulin, macroglobulin, and complement factors is formed132. Such a 
transformation alters the “biological identity” of the NPs. In turn, NPs also change the 
conformation and function of adsorbed proteins133. Therefore, understanding the formation 
and properties of protein corona is essential for clinical translation of nanomedicine.  
 
One way to control protein corona formation is through NPs surface modification134. For 
example, Wurm et al. investigated the stealth effect of poly (ethylene glycol) (PEG) or poly 
(ethylene glycol phosphate) (PEEP) on polystyrene (PS) NPs. It was shown that pre-
incubation NPs with clusterin reduced non-specific cellular uptake compared to non-
functionalized NPs135. To develop a targeting drug delivery system, a fusion protein 
containing HER-2 binding affibody combined with gluthathione-S-transferase was pre-
coated on mesoporous silica nanoparticles (MSN). The corona formed by the fusion protein 
subsequently reduced non-specific interactions with serum proteins, avoided clearance by 
macrophages, and ensured systemic targeting for in vitro and in vivo delivery136. It was 
also shown that hydrophobicity and chemical functional groups on the surface of AuNPs 
controlled the nature of protein corona and subsequently cellular uptake by macrophages137. 
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Chirality of nanoparticle surfaces is another important factor that can influence the protein 
corona. Chirality is a common phenomenon in living systems. For example, almost all the 
amino acids in protein are left-handed. All sugars in DNA and RNA are “right-handed”. 
Recently, the influence of NPs surface chirality on the protein corona has received more 
attention. For example, transferrin is a widely used tumor-targeting ligand in cancer 
treatment and diagnosis. Wang et al. showed that the chiral surface of gold nanoparticles 
(AuNPs) determined the orientation and conformation of transferrin, affecting the 
interaction between transferrin and its receptor in the cellular membrane138.  Similarly, the 
adsorption of bovine serum albumin (BSA) on the chiral surface of AuNPs was 
investigated. BSA was shown different adsorption behavior in different chiral surfaces, 
which was primarily driven by the salt bridge. When interacting with cells, AuNPs (L)-
BSA showed significantly higher uptake than AuNPs (D)-BSA after 3 h incubation139.  
 
Moreover, chiral NPs were also developed to explore their potential applications in disease 
treatment and prevention. For instance, Chiral glutathione (GSH) anchored selenium NPs 
(G@SeNPs) were fabricated to investigate the influence of chirality on their transport and 
antioxidant activity. It was found that L- G@SeNPs showed strong homogeneous cell 
adhesion and uptake, thus effectively preventing oxidation damage insulinoma cells140. 
Chirality-selective autophagy activation was observed in triple negative breast cancer cell 




Although progress has been made to elucidate the influence of nanoparticle chirality on 
protein adsorption and explore its therapeutics applications, one limitation is that most of 
the studies have focused on organic chiral compounds coated on the inorganic 
nanoparticles such as AuNPs, SeNPs, and quantum dot142. There is a great need to 
systematically investigate the impact of opposite chirality of pure organic nanoparticles on 
the protein corona formation, cellular uptake, and subsequent biological functions.  
 
Inspired by carbohydrate polymers in nature, poly-amido-saccharide (PAS) is a novel class 
of biomaterials. Their monomers are linked by an a-1,2-amide linkage, which is resistance 
to enzymatic and hydrolytic degradation and possess a unique helical conformation143. It 
also shares many properties with natural polysaccharide such as hydrophilicity, densely 
functionalized hydroxyl groups, and rigid backbone. Unlike natural carbohydrate polymers, 
PAS is a pure and well-defined polymer with a precisely control over molecular weight 
distribution and functionality installments. Since its introduction in 2012, PASs have 
shown great promise in various biomedical applications144. For example, carboxylated 
PASs retained 80% lysozyme activity following 10 lyophilization cycles acting as a 
lyoprotectant with greater protective ability than that of trehalose145. Amine functionalized 
PASs were demonstrated to adhere to the mucus, given the structure similarity to 
chitosan146. Bacteria growth was inhibited when incubating with PAS-fatty acid 
amphiphiles147.  
 
Although great progress has been made to synthesize functionalized PAS, there has been 
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no reports for a PAS-based amphiphilic block copolymer. Considering the wide biomedical 
applications of natural polysaccharides such as alginic acid, chitosan, and hyaluronic acid 
in drug, gene, and cell therapies32,76,77, the well-defined PAS-based nanomedicine could 
provide great alternatives in the future. To facilitate the translation of PAS block 
copolymers-based nanomedicines to the bedside, a critical step is to understand the 
compositions of protein corona and subsequent biological functions in living systems. One 
important factor to consider is the influence of opposite surface chirality imparted by 
helical conformation of PAS.  
 
To develop a PAS-based chiral amphiphilic block copolymer, we chose to combine 
optically-active PAS domains with optically-active poly-L-lactic acid (PLLA), which is 
chosen as the core-forming domain to facilitate the self-assembly process in aqueous 
solution82. Here, we present the first synthesis and characterizations of chiral PLLA-b-PAS 
block copolymer. PAS and PLLA were conjugated end-to-end utilizing an inverse electron-
demand Diels-Alder reaction due to its robust reactivity and selectivity. The resulting chiral 
block copolymer can then self-assembly into diamond-shape NPs when dissolving in water. 
To build a foundation to understand the influence of PAS chirality, the protein 
compositions on the surface of PLLA-b-PAS NPs were able to identify and analyze by 
SDS-PAGE and liquid chromatography-coupled to mass spectrometry (LC-MS/MS) in 
comparison to hydrophobic polystyrene (PS) NPs control. These promising early results 
provide insight for design studies to better understand of the influence of PAS chirality on 
the NPs - protein interactions, cellular uptake behaviors, and ultimately rational design of 
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4.3 Results and Discussion  
4.3.1 Synthesis and Characterization of PLLA-b-PAS  
To synthesize alginate-b-PLA diblock copolymers, PAS-tetrazine is ligated with the PLA-
TCO (Figure 4.1). When synthesizing alginate-based block copolymers, it is notable that 
one major challenge is the solubility difference between water-soluble sodium alginate and 
hydrophobic macromolecules such as PLA and PLA-b-PEG. In order to improve the 
organic solubility, sodium alginate-tetrazine was converted into its tetrabutylammonium 
(TBA) salt, which was subsequently readily solubilized in aprotic solvent such as DMF or 
DMSO. However, when ligating between hydrophilic PAS-tetrazine and hydrophobic 
PLA-TCO, the reaction proceeded to completion in a DMF/water suspension system 
demonstrating the superior reactivity between tetrazine and TCO mediated inverse 
electron-demand Diels-Alder reaction. The final diblock copolymers were characterized 
by1H-NMR, UV-Vis spectrometer and FT-IR (Figure 4.2 and 4.3).   
 
When dissolving in D2O, the characteristic peaks of PLA were not observed in PLLA-b-
PAS diblock copolymers, only peaks consistent with the PAS backbone. The loss of proton 
signals from the polylactide in D2O indicated that the diblock copolymer exhibited 
potential hydrophobic aggregation in solution (Figure 4.1). Diagnostic peaks for tetrazine 
(7.42 and 8.23 ppm) from the alginate-tetrazine and TCO functionalities from the diblock 





Figure 4. 1. Synthesis and 1H-NMR characterization of PLLA-b-PAS diblock copolymer. (A) 
Reaction scheme of PLLA-b-PAS diblock copolymer. (B) 1H-NMR characterization of PLLA-b-





Figure 4. 2. FTIR characterization of PLLA-b-PAS diblock copolymer. (A) FTIR spectra of PLLA-
TCO and the signature peaks were marked on the spectrum. (B) FTIR spectra of PAS-tetrazine and 
the signature peaks were marked on the spectrum. (C) FTIR spectra of PLLA-b-PAS and the 
signature peaks were marked on the spectrum. 
FTIR analysis of PLLA-b-PAS showed the anticipated stretching vibrations of OH groups 
from PAS at 3330 cm-1, as well as the amide I and II bands appeared in 1670 and 1510   
  
 110 
cm-1 (Figure 4.2). The stretching of C=O from the polylactide was identified at 1760 cm-1 
along with -CH stretching at 2961 cm-1 (Figure 4.2). For UV-Vis spectrum, the signature 
of PAS-tetrazine at 525 nm disappeared after conjugated with PLLA-TCO indicating the 
full consumption of tetrazine functionality (Figure 4.3). Taken together, these 
characterizations confirmed the synthesis of the PLLA-b-PAS diblock copolymer. 
 
 
Figure 4. 3. UV-Vis characterization of PAS-tetrazine (red) and PLLA-b-PAS (black). The full 
consumption of tetrazine moiety was observed with disappearance of signature peak at 525 nm.  
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4.3.2 Self-Assembly of PLLA-b-PAS Nanoparticles   
The PLLA-b-PAS can self-assemble into nanoparticles by directly dissolving in water 
without any formulation strategy needed. Figure 4.4 A–C shows circular dichroism spectra 
of individual chiral polymer (PLLA and PAS) as well as PLLA-b-PAS nanoparticles. The 
chirality of PLLA-b-PAS NPs is dictated by the PAS-tetrazine suggesting the hydrophobic 
aggregation of PLLA domain, which was also supported by the loss of proton of PLLA in 
1H-NMR when dissolving in D2O. The hydrodynamic radius and morphology of 
nanoparticles were characterized by dynamic light scattering (DLS) and scanning electron 
microscopy (SEM) (Figure 4.4 D and E). The DLS showed the mean diameter of 29.56 
nm (PDI =0.205) but the diameter is ranged from 83.19 to 387.8 nm based on SEM. The 
measured size difference between DLS and SEM can be resulted from the diamond-like 
morphology of PLLA-b-PAS NPs since the DLS measures spherical particles.  
 
Chiral block copolymers (CBPs) have reported to self-assemble into various ordered phase. 
For example, a well-organized and hexagonally packed PLLA left-handed helices were 
formed from the self-assembly of poly (styrene)-b-poly (L-lactide)148. Soto and co-workers 
also synthesized a series of polyphosphazenes based chiral block copolymer, which self-
assembled into various morphologies ranging from helical nanostructures, pearl-necklace 
aggregates to nanospheres by modulating the ratio between chiral and non-chiral units149. 
Similarly, as shown in Figure 4.4E, PLLA-b-PAS NPs exhibited well-organized polygonal 
structure. In the future, a series of chiral block copolymer containing different lengths and 
chirality of PLA and PAS domains will be synthesized to better understand the morphology 
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Figure 4. 4. Chirality, size, and morphology characterizations of PLLA-b-PAS NPs. (A) Circular 
dichroism spectra of PLLA-TCO (dichloromethane). (B) Circular dichroism spectra of PAS-
tetrazine (DI water). (C) Circular dichroism spectra of PLLA-b-PAS (DI water).  (D) The size 
distribution of PLLA-b-PAS NPs measured by DLS. (E) The morphology of PLLA-b-PAS NPs 





Figure 4. 5. Different concentrations of PLLA-b-PAS NPs and PS NPs were incubated with mouse 
serum for 1 hour. The protein corona content attached to the surface of NPs was visualized and 
determined by SDS-PAGE 
 
4.3.3 SDS-PAGE and Proteomics Study of PLLA-b-PAS NPs  
To simulate the in-vivo behavior of PLLA-b-PAS NPs behavior in blood, the NPs were 
incubated with mouse serum for 1 hour at 37 °C.  The hard protein corona adsorbed on the 
surface was isolated by repetitive centrifugation and analyzed by SDS-PAGE (Figure 4.5). 
Dose-response was observed when increasing the concentration of PLLA-b-PAS NPs from 
0.4% (4 mg/ml) to 2% (20 mg/ml). Major protein bands were observed at 100, 50, 37, 25, 
and 10 kDa. The quantitative analysis of the adsorbed proteins on the nanoparticles’ surface 
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was measured by liquid chromatography-coupled to mass spectrometry (LC-MS/MS)-
based proteomics study. The protein corona profile of PLLA-b-PAS NPs was compared to 
PS NPs, common hydrophobic NPs. LC/MS/MS-based proteomics study has proven to be 
a powerful tool to quantitatively understand the nanoparticle-protein interaction. As shown 
in Figure 4.6A, a total of 498 proteins is identified from both samples, among which there 
are 22 proteins uniquely to PLLA-b-PAS NPs. Within 22 identified proteins, 27.27% 
proteins are associated with cytoskeleton and cell mobility, followed by proteins in 
immunological systems (18.18%). 22.73% proteins are responsible for response to 
different stimuli including oxidative stress, DNA damage and allergic/inflammation 
followed by transportation including transferrin, fatty acid, and protein trafficking 
(18.18%).  
 
To better understand the influence of chirality on the protein corona profile in the future, 
in comparison to PLLA-b-PAS (right hand), PDLA-b-PAS (left hand) will be synthesized 
and incubated with mouse serum followed by LC/MS/MS-based proteomics study. 
Similarly, protein corona profiles of PLLA-b-PAS (right hand) and PDLA-b-PAS (left 
hand) will be compared to identify unique proteins belonging to each PLA/PAS chiral 
block copolymer. In addition, the amount of identified proteins adsorbed on the surface of 
PLA/PAS block copolymer NPs will also be compared. The information gathered from 
proteomics study will provide a deeper insight to probe the interaction between surface 
chirality and serum proteins, which will provide a roadmap to understand the in-vivo fate 
of PLA-b-PAS NPs, identify potential cellular localizations, and explore potential 
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therapeutic applications of PAS-based nanomedicines. 
 
Figure 4. 6. Proteomics study of surface protein corona adsorbed to PLLA-b-PAS and PS NPs. (A) 
Numerical analysis of surface protein corona between PLLA-b-PAS and PS NPs.  (B) Molecular 




4.4 Material and Methods  
4.4.1 Chemicals and Instrumentation  
Unless otherwise mentioned, all chemicals and bio-reagents were purchased from Sigma-
Aldrich, Fisher Scientific, Alfa-Aesar, Acros, Click Chemistry Tools or Bio-rad. Reactions 
were carried out under nitrogen using standard techniques, unless otherwise noted. 1H-
NMR spectra were acquired on a Varian INOVA 500 MHz spectrometer. Infrared 
spectroscopy (IR) was performed on a Nicolet FT-IR with a horizontal attenuated total 
reflectance (ATR) adapter plate. The polymer weight of PAS and was determined by GPC 
versus dextran standards using aqueous buffer (0.2M NaNO3, 0.01 M phosphate buffer, pH 
7.5) as the eluent at the rate of 0.50 ml/min through two Agilent PL aquagel columns (OH 
MIXED-M and OH 30, 7.5´ 300 mm) at 25 °C with a refractive index detector. UV-Visible 
spectra were recorded on Agilent Cary 3500. Circular dichroism (CD) spectra of PLLA, 
PAS, and PLLA-b-PAS were obtained using a ChirascanTM spectrometer (Applied 
Photophysics, MA, USA) with samples in a 1-cm quartz cuvette.   
 
4.4.2 Polymer Synthesis and Characterizations  
4.4.2.1 Lactam Synthesis  
 
Scheme 4. 1. Synthesis of Lactam Monomer 
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A solution of 3,4,6-benzylglucal (5 g, 12.00 mmol, 1 eq.) in toluene (20 mL) was added 
dropwise to a solution of chlorosulfonyl isocyanate (1.567 mL, 18.01 mmol, 1.5 eq.) and 
sodium carbonate (2 g, 18.01 mmol, 1.5 eq.) in toluene (20 mL) at -78°C using an acetone 
bath cooled with dry ice. The temperature was then changed to -60°C by changing the cold 
bath for a chloroform bath cooled with dry ice and the reaction mixture was stirred at this 
temperature for 4h. The temperature was then lowered again to -78°C and the reaction 
mixture was diluted by slow dropwise addition of 60 mL of toluene. A 60 w% solution of 
Red-Al in toluene (6.44 mL, 19.81 mmol, 1.65 eq.) was added dropwise and the reaction 
mixture was stirred at -78°C during 30 minutes. The temperature was then allowed to warm 
up gradually at -63°C (chloroform bath), -20°C (70/30 water/methanol bath) and 0°C (ice 
bath). 2 mL of water were added and a white solid formed which was filtered. The filtrate 
was diluted in Et2O and washed with a 1M aqueous HCl solution, a saturated aqueous 
NaHCO3 solution and brine. The organic extract was dried over sodium sulfate, filtered, 
and the solvents were evaporated under reduced pressure. Purification by silica gel 
chromatography using a 70/30 cyclohexane/EtOAc mixture as eluent provided 1.905 g 
(35 %) of the pure lactam as a clear oil which solidified upon standing. Spectroscopic and 
mass characterization data matched those previously reported.  
4.4.2.2 Synthesis of Cbz-protected PAS  
 
Scheme 4. 2. Synthesis of Cbz-protected PAS  
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In an oven-dried flask under argon, the lactam (1.692 g, 3.68 mmol) was dissolved in 23 
mL of dry THF over 4 Å molecular sieves. The reaction flask was cooled to 0°C in an ice 
bath and the initiator (0.027 g, 0.074 mmol, 2.0 mol %) was added as a solution in dry THF 
(1.5 mL). A solution of LiHMDS (30.8 mg, 0.18 mmol, 5.0 mol %) in dry THF (0.5 mL) 
was added and the solution was stirred for 30 min at 0°C then for 30 minutes a room 
temperature (reaction progress was monitored by observing the disappearance of the 
monomer using TLC). After total consumption of the reaction, a drop of saturated NH4Cl 
solution was added to quench the reaction and THF was evaporated. The resulting solid 
was redissolved in diethyl ether (50 mL) and washed with 1 M HCl, saturated NaHCO3, 
and brine. After drying over sodium sulfate and filtration, the solvent was evaporated from 
the filtrate. The crude product was then redissolved in a minimum amount of 
dichloromethane and the polymer was precipitated by dropwise addition into a flask of 
stirred, cold pentane (500 mL), then collected by filtration. After drying under high vacuum, 
1.305 g (77 %) of an amorphous solid was isolated. Spectroscopic characterization data 
matched those previously reported.  
 
4.4.2.3 Synthesis of amine terminated PAS  
 
Scheme 4. 3. Synthesis of amine-terminated PAS  
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A 500 mL three-neck flask was half-filled with liquid ammonia by condensation at -60°C 
and 4 pieces (approximately 2 mm3) of metallic sodium were added. The reaction mixture 
turned deep blue. In a vial under argon, a solution of LiHMDS (0.627 g, 3.75 mmol, 1.5 
eq. compared to monomer) in dry THF (2 mL) was added to a stirred solution of the 
polymer (1.148 g, 2.50 mmol considering the molar mass of one monomer) in dry THF (5 
mL). The resulting solution was added dropwise to the Na/NH3 solution and the reaction 
mixture was stirred at -60°C for 2h. A saturated aqueous NH4Cl solution was added 
dropwise until disappearance of the blue color to quench the reaction and the flask was 
opened overnight to let the ammonia slowly evaporate. The remaining aqueous solution 
was washed twice with diethyl ether, filtered with a 0.45 μm pore size filter and dialyzed 
with 1000 MWCO tubing for 1 day with 3 water changes. After lyophilization, 0.435 g 
(92 %) of a white amorphous solid was isolated. Spectroscopic characterization data 
matched those previously reported.  
 
4.4.2.4 Methyl-tetrazine PAS  
 
Scheme 4. 4. Synthesis of methyl tetrazine functionalized PAS 
 
The polymer (297 mg, 0.031 mmol, 1 eq.) was dissolved in a solution of NaHCO3 (3 mg, 
0.033 mmol, 1.05 eq.) in 30 mL of DI water and a solution of NHS-methyl-tetrazine (15mg, 
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0.047 mmol, 1.5 eq.) in DMSO (0.5 mL) was added dropwise. The reaction mixture was 
stirred at room temperature during 17h then transferred in a separation funnel and washed 
three times with dichloromethane to remove any unreacted methyl-tetrazine reagent. The 
aqueous layer was recovered and dialyzed for 1 day against DI water (the water was 
changed 4 times). The product was recovered as a pink amorphous solid after lyophilization. 
Integration of the two aromatic signals at 7.42 and 8.23 ppm for the tetrazine relative to the 
protons of each repeating unit of PAS backbone reveals at least 98% coupling efficiency. 
GPC: Mw= 8013 g/mol, Mn= 7284.5, PD= 1.1  
 
4.4.2.5 PLLA-b-PAS  
In a typical reaction, methyl tetrazine-PAS (50mg, 0.006mmol, 1eq.) in a 20 ml 
scintillation vial equipped with stir bar and 5 ml of PLLA2.5K-TCO in DMF solution 
(22.5mg, 0.009mmol, 1.5 eq.) was added. A cloudy pink suspension was obtained. 100 µl 
water was then added, and the reaction suspension was stirred for another 4 hours. After 4 
hours, the pink color disappeared indicating the consumption of tetrazine moiety. The 
reaction suspension was then dialyzed against water to remove DMF followed by 
lyophilization. The reaction crude was then washed three times by dichloromethane and 
collected white precipitation was re-dissolved in water. After lyophilization, 52.4mg (80%) 
of a white amorphous polymer was obtained. The 1H-NMR, FTIR, and UV-Vis 




4.4.3 Nanoparticle Fabrication and Characterizations  
The PLLA-PAS NPs was prepared by dissolving polymer (4mg) in the 1ml water directly.  
The morphology of NPs was visualized using scanning electron microscope. Briefly, the 
samples were sputter coated at 20 mA fot 12 seconds at AuPd target (Cressington 106). 
Once coated, scanning electron mcirographs were taken with the Zeiss Supra 55 at 3kV e-
beam voltage. Hydrodynamic diameter of PLLA-PAS NPs was determined using 
NanoBrook Omni (Brookhaven Instruments, NY, USA).  
 
4.4.4 Mouse Protein Corona Preparation  
PLLA-PAS and Polystyrene (PS) NPs prepared in MilliQ water was incubated with mouse 
serum for 1 hour with 1h constant agitation at 37°C. The hard protein corona was purified 
based on previous report with modification150. Briefly, the nanoparticles were separated 
from the supernatant by centrifugation at 17 000 ´g for 30 min three times followed by 
resuspension in 1 ml 1´ PBS at 4°C. Before the last washing step, the dispersion was 
transferred to a new tube. After the final wash, 200 µl of SDS-Tris-HCl buffer (40mg SDS 
+ 125 µl Tris-HCl + MiliQ water up to a total of 2ml) was added and incubated by shaking 
at 95°C for 15 min. The protein was isolated by centrifugation at 17 000 ´g for 30 min at 




4.4.5 Determination of the Protein Corona by Sodium Dodecyl Sulfate-Polyacrylamide 
Gel Electrophoresis (SDS-PAGE) 
A total of 3 µl of the protein sample was mixed with 1 ´ protein loading buffer (12 µl 
MiliQ water and 5 µl 4 ´ Laemmli buffer containing reducing agent 2-mercaptoethanol) 
for SDS-PAGE. Then, the mixtures were then incubated for 5 min at 95 °C. The SDS-
PAGE was run for 1 hour at 110 mV before protein bands were visualized by the 
Coomassie Brilliant Blue corresponding to the manufacturer instructions (Bio-rad, CA, 
USA).  
 
4.4.6 LC-MS based Proteomics Analysis  
The protein samples were digested with trypsin on a S-trap micro column and injected into 
our Thermo Orbitrap Fusion Lumos Mass Spectrometer for the LC-MS/MS analysis. The 
data was searched against SwissProt Mouse database using Mascot server through 




Chapter 5 Future Work 
5.1 Abstract  
This thesis described the synthesis and characterization of a series of polymer mosaics with 
emergent physicochemical properties, novel functionalities, and defined secondary 
structures. For future directions, the potential of alginate-b-PEG-b-PLA NPs as a controlled 
delivery platform for cancer treatments will be evaluated both in-vitro and in-vivo. The 
alginate/PEG/PLA triblock NPs can be further modified as targeted drug delivery system 
through surface modifications. Additionally, the degradation mechanism of alginate-b-
PLA chimeras hydrogels can be further characterized by covalently conjugating a 
fluorescent probe to the PLA end. This alginate-b-PLA degradable hydrogel can also be 
explored as a sacrificial matrix for tissue engineering. Lastly, a library of polymer mosaics 
by diversifying biomaterial domains can be built to fabricate cell-laden scaffolds and 





5.2 Pre-Clinical Evaluation of Alginate/PEG/PLA Triblock Copolymer NPs for 
Cancer Treatment  
In chapter 2, the synthesis and self-assembly of alginate-b-PEG-b-PLA triblock copolymer 
was successfully demonstrated. Furthermore, various payloads with different 
hydrophobicities were also successfully encapsulated and subsequently released from 
polymer mosaic NPs. The triblock copolymer NPs were shown enhanced cellular uptake. 
However, there is a great need to understand how the abilities of alginate/PEG/PLA 
triblock copolymer NPs to encapsulate and release different drugs with controllable 
kinetics will translate into clinical settings especially as combination therapy to treat 
cancers.  
 
As a starting point, a thorough screening of small molecules is needed to identify 
therapeutic payloads for in-vitro and in-vivo evaluations. The criteria of success drug 
combination include: (1) drug candidates demonstrate good encapsulation efficiency 
(>35%); (2) drug candidates shows enough temporal release resolution in terms of 
percentage of release (>25%); (3) The release kinetics plays an important role in enhancing 
synergistic effect of combination therapy.  
 
Alternatively, the unmodified alcohol group in the PLA domain makes it an attractive 
attaching point for modulating drug release kinetics. For example, both doxorubicin and 
erlotinib release in a similar rate when encapsulating into alginate/PEG/PLA polymer 
mosaic NPs. However, Yaffe et al. demonstrated that triple-negative breast cancer (TNBC) 
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cells and non-small lung cancer (NSCLC) cells are dramatically sensitized to DNA-
damaging chemotherapy (doxorubicin) after EGFR signaling is suppressed151. A triblock 
copolymer-doxorubicin conjugate can potentially address this challenge in our current 
system. By covalently attachment of doxorubicin to the end of alginate/PEG/PLA triblock 
copolymers through ester linkage, it is expected to reduce the rapid burst release of 
doxorubicin after self-assembly and release kinetics is primarily controlled by hydrolysis, 
which would potentially favor the synergistic effect between doxorubicin and erlotinib. 
The unmodified latent carboxylic acid group on the alginate backbone also make it 




Figure 5. 1. Preclinical proof of concept studies of alginate/PEG/PLA polymer mosaics NPs as 




Preclinical proof-of-concept experiments could be added after successfully screening 
combination therapy candidates and optimizing the alginate/PEG/PLA polymer mosaic 
NPs. For doxorubicin and erlotinib, the cytotoxicity of the nanoparticles can be assessed in 
BT-20 (TNBC) and A549 (NSCLC) cell lines. The percentage of apoptotic cells and key 
protein expression levels such as pERK and cleaved caspase-8 can be used when 
comparing dual- drug loaded polymer mosaic nanoparticles with single drug nanoparticles 
as well as dual drugs. The in-vivo performance of dual-drug loaded nanoparticles can be 
evaluated in luminescent xenograft tumor models where BT-20 and A549 cells are 
transfected with a firefly luciferase plasmid. This enables assessment of tumor size by a 
visual and quantifiable luminescent read out. The dual-drug loaded nanoparticles are 





5.3 Hydrogel Degradation Characterizations using Fluorescence-Labeled Alginate-
b-PLA  
In chapter 3, the synthesis and fabrication of degradable alginate-b-PLA hydrogels were 
successfully demonstrated. Moreover, the degradation process was characterized by 
rheological measurement and proton NMR. It was shown that the degradation started at the 
swelling equilibrium and associated with PLA degradation. However, the correlation 
between hydrogel degradation and PLA hydrolysis has yet to be determined. Therefore, it 
would be essential to fully understand the impact of PLA domain on the alginate/PLA 
hydrogel degradation.  
 
In future work, fluorescently labelled hydrogels will be synthesized by covalently 
conjugating TAMRA to the end of alginate-b-PLA. The hydrogel degradation can then be 
characterized by monitoring TAMRA cleavage quantitatively using UV-Vis spectroscopy 
over time. The cleavage profile of TAMRA from hydrogel would provide a deeper insight 
into PLA distribution within hydrogels. For example, if the cleavage profile follows a first-
order kinetics, it could indicate a homogeneous distribution of PLA within hydrogel. 
Alternatively, if the cleavage profiles consist of “burst release” and “sustained release” 
phases, it could indicate a heterogeneous distribution of PLA within hydrogel matrix. In 
this case, a portion of TAMRA is located closer to the surface of hydrogel. The rest of 
florescent molecules might be entrapped inside the hydrogels induced by hydrophobic 
aggregation of PLA. Furthermore, the inner structural change of hydrogels during 
degradation process can be visualized by confocal microscopy. Taken together, 
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5.4 Alginate-b-PLA Degradable Hydrogels for Tissue Engineering  
Degradation is a key factor when designing hydrogel scaffold for tissue engineering 
application. Degradation permits cell proliferation, migration, infiltration of new blood 
vessels, and matrix remodeling109. In future work, the potential application of alginate-b-
PLA degradable hydrogels for tissue engineering will be explored. For example, the cell 
compatibility will be assessed in both 2D and 3D cell culture using a mouse pre-osteoblast 
cell line. The morphology, proliferation, and viability will be evaluated between 
degradable alginate/PLA hydrogels and a non-degradable alginate control. To determine 
the in-vivo performance of alginate-b-PLA degradable hydrogels, the scaffolds can be 
implanted subcutaneously into the backs of mice followed by a histological evaluation. 
Compared to non-degradable alginate hydrogels, the degradable hydrogels are expected to 
fall apart, which permits cellular infiltration. Moreover, the unmodified latent and end 
functionalities on the alginate and PLA domains (carboxylic acid and alcohol) could also 
be used as attaching points for cell-adhesive peptide (i.e. RGD) and cytokines to further 





5.5 Diversification of Polymer Mosaics by Incorporating Other Biomaterial 
Domains  
This thesis is focused on polymer mosaics primarily consisting of alginate, PEG, PLA, and 
PAS. There is also a great need to diverse the polymer mosaics library by incorporating 
other attractive biomaterial domains. For example, cyclic oligosaccharides like 
cyclodextrins allow for a non-covalent host-guest crosslinking strategy where crosslink 
density and porosity can be controlled152. Stimuli-responsive behaviors such as pH, light, 
temperature, and redox can also achieved by modulating the guest molecules153. A 
thermoresponsive behavior would be obtained by introducing polymer (N-
isopropylacrylamide) (PNIPAM). The inclusion of protein/peptide domains are also 
favorable when fabricating cell-responsive scaffolds. For example, the incorporation of 
DNA domains can provide natural templating of complementary polymer mosaic chains, 
adding another element of control to the nanostructures of the scaffold154.  
 
In conclusion, by mimicking the way that nature assembled materials, our modular 
synthesized domain-structured single-chain polymers will have a great impact on the 
material design with structural complexities, complementary physicochemical properties 
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